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It has been observed that Mycobacterium bovis bacille Calmette-Guérin (BCG) 
vaccination does not confer additional protection against tuberculosis in human 
populations sensitised by exposure to antigens of environmental mycobacteria (Env). In 
mice primed by certain Env species followed by BCG vaccination, there is reduced in 
vivo proliferation of BCG.  These studies suggest that immunity derived from Env 
sensitisation could aid in combating subsequent M. tuberculosis infection, and also 
influence the efficacy of BCG vaccination, but the immune mechanisms remain unclear. 
In this project, cytotoxic activity of Env-responding T cells against autologous BCG-
infected macrophages was evaluated in peripheral blood mononuclear cells of healthy 
adults and splenocytes of Env-immunised mice. T cell subsets and cytokines involved in 
the cytotoxic activity were also examined. Additionally, the protective mechanisms of 
Env immunisation were further studied with murine BCG challenge. In humans, the Env-
specific cytotoxic activity was CD4+ T cell-dependent but interferon-gamma 
independent. Cross-protective cytotoxic responses upon restimulation with other 
mycobacteria were most significant in M. chelonae-sensitised mice, and weakest in BCG-
immunised mice.  In addition, murine immunisation with M. chelonae conferred 
significantly reduced BCG organ load upon intranasal challenge, with reduced 
inflammatory cells in the lungs, but increased splenic lymphocyte proliferation against 
BCG antigens. Overall, the data provide evidence for Env-mediated protection against 
pathogenic mycobacteria, and suggest mechanisms for reduced efficacy of BCG 
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CHAPTER 1  INTRODUCTION 
1.1 Epidemiology of Tuberculosis 
Tuberculosis (TB) is chiefly caused by members of the Mycobacterium tuberculosis 
(Mtb) complex, comprising M. tuberculosis, M. bovis, M. africanum and M. microti.  TB 
is responsible for approximately 2 - 3 million human deaths every year worldwide. The 
World Health Organisation (WHO) has declared TB as a global emergency as it is 
estimated that there are eight million new cases each year (The World Health Report 
2000). It is a curable disease which requires a minimum of 6 months of treatment with an 
antibiotic cocktail. However, in some developing countries, access to drugs and 
compliance with the treatment regimen is poor. The live attenuated Mycobacterium bovis 
bacille Calmette-Guérin (BCG) has been widely used as a TB vaccine for more than 80 
years, and is given to newborn infants in Singapore and most developing countries. 
However, its protective efficacy against adult TB is variable in different geographical 
regions, and recent trials in developing countries have shown little protection (Colditz et 
al., 1994). There are scientific concerns about reasons why BCG fails and the lessons 
from such studies are likely to be applicable to any potential new TB vaccine. This 
present project was designed to try to understand some of these reasons for the failure of 
BCG, with a focus on the role of prior sensitisation with environmental mycobacteria 
(Env). 
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1.2 Immunity to Tuberculosis 
In both humans and mice, protective immune responses to TB are dependent on cell-
mediated immunity provided by T cells. Appropriate CD4+ T cell activity appears to be 
most important, as is clearly demonstrated by the impact of HIV infection, which causes 
significant reduction of CD4+ T cell numbers and marked susceptibility to tuberculosis 
(Flynn et al., 2001; Elkins et al., 2003). The full range of effector mechanisms of CD4+ T 
cells are still being investigated, but clearly include some functions such as induction of 
interferon-gamma (IFN-γ) and tumour necrosis factor-alpha (TNF-α) for the activation of 
macrophages, resulting in the production of toxic reactive oxygen and nitrogen species, 
as well as the induction of CD8+ T cell cytotoxic activity (Schaible et al., 1999; Flynn, et 
al., 2001). 
 
1.3 Induction of memory T cells to Tuberculosis 
Upon encountering intracellular pathogens such as M. tuberculosis, macrophages and 
dendritic cells are early producers of interleukin-12 (IL-12), which activate type 1 helper 
T cells (Th1) to produce essential macrophages-activating cytokines such as IFN-γ, to 
limit the growth and replication of the pathogen within the macrophages. After the acute 
responses of these T cells, most of the effector cells undergo apoptosis and a small subset 
develop into a long-term memory T cells. The induction and maintenance of these 
memory T cells is also the basis for successful vaccination. BCG is given as a live 
vaccine, and it has been shown that active multiplication of BCG in the host is essential 
for the inducing good memory responses subsequently (Fine, 1995). 
 3
1.4 Effect of pre-exposure to environmental mycobacteria (Env) on subsequent 
BCG vaccination 
BCG confers minimal or no protection at all in clinical trials conducted in some tropical 
regions, especially in Asia and Africa, but good protective efficacy in the UK. Although 
the mechanisms are still poorly understood, there are several postulations. Apart from the 
different BCG strains used in vaccinations, there are differences in the ages of 
people given the vaccine and the route of vaccination. However, the hypothesis of 
greatest interest currently is the effect of prior exposure of environmental mycobacteria 
(Env) on protective efficacy of BCG (Fine, 1989).  
 
Orme et al first showed that the BCG vaccine does protect mice which are pre-sensitised 
with Env (Orme et al., 1986). Studies by Brandt L et al showed that Env species which 
proliferated better in mouse organs were able to block the replication of BCG, resulting 
in the abrogation of its protection against subsequent Mtb infection (Brandt et al., 2002). 
Recent studies suggested that blocking of BCG replication is more efficient when the 
extent of shared antigens between priming strain and BCG is high (Demangel et al., 
2005). In addition, previous studies also showed that adoptive transferring of whole 
splenocytes from M. intracellulare-immunised mice conferred cross-protection against 
Mtb infection (Takashima et al., 1988), thus it is clear that the Env species may confer 
some degree of protection on their own. However, the specific cell types involved and the 
mechanisms resulting in cross-protection conferred through Env-induced immunity have 
yet to be described. 
 4
1.5 Objectives and scope of project 
 The objectives of this project are: 
1) In a cohort of healthy, BCG-vaccinated local adults, to characterise the nature 
and diversity of Env responses and determine if divergent Env responses are 
associated with differential anti-tuberculosis responses. 
2) In mice sensitised to selected species of Env, to characterise the nature and 
extent of cross-reactive cytotoxic responses in Env-responding T cells, and 
investigate the T cell subsets and cytokines involved. 
3) To examine the immunomodulatory properties of Env immunisation and the 














CHAPTER 2  LITERATURE REVIEW 
 
2.1 Intracellular lifestyle of Mycobacterium tuberculosis 
Tubercle bacilli are taken up by alveolar macrophages, which are believed to be their 
principal host cells, upon infection through inhalation of an infectious aerosol. The 
bacteria resist intracellular microbicidal mechanisms by subverting phagosome 
maturation of the macrophages and by sequestering of the harsh environment by their 
protective lipid-rich cell walls (Schaible et al., 1999). Inflammatory cytokines released by 
infected cells and presentation of Mtb antigens recruit Th1 cells from the draining lymph 
nodes, resulting in enhanced mycobactericidal ability of the macrophages. Strong cell-
mediated immunity is a key requirement for preventing the bacteria from multiplying. 
The bacilli are sequestered within a granuloma consisting of macrophages surrounded by 
T cells of varying activation status. Persistent T cell activation leads to the apoptosis of 
infected cells and caseous necrosis within the granuloma.  However, the remaining viable 
Mtb can persist asymptomatically within the host for decades, as evidenced by 
reactivation of the latent infection subsequently. It is thought that latent mycobacteria 
may survive by reducing their metabolic activity and persisting in a non-dividing or 
slowly dividing state, which facilitates their survival under conditions of nutrient and 
oxygen deprivation within the granuloma (Raja, 2004). 
2.2 Cytotoxicity in response to Mtb 
There are conflicting reports on the importance of cytotoxic T lymphocytes (CTLs) in 
protecting the host against Mtb. Theoretically, lysis of Mtb–infected macrophages could 
be beneficial to the host if the released bacilli are subsequently engulfed and killed by the 
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surrounding more proficient macrophages. Lysis of Mtb-infected murine macrophages by 
CD4+ and CD8+ T cells could cause death of the bacteria by either the perforin- or 
Fas/FasL-pathway (Silva et al., 2000). Silva et al have suggested that lysis of infected 
macrophages is a prerequisite for killing intracellular mycobacteria (Silva et al., 2001). 
However, others suggest that host cell lysis through the Fas/FasL-pathway does not lead 
to killing of intracellular Mtb (Stenger et al., 1997). Nonetheless, the level of cytolytic 
activity of CD4+ and CD8+ T cells of tuberculosis patients is lower than healthy PPD+ 
individuals and decreases gradually as the disease becomes more severe (De La Barera et 
al., 2003), suggesting that cytolytic activity is relevant to immune protection.  
 
Cell subsets that are potentially involved in lysis of Mtb-infected macrophages are CD4+ 
T cells, CD8+ T cells, γδ T cells and NK cells (Flynn, 2001). 
 
2.2.1  CD4+ T cells  
Some of the antigens secreted early by Mtb in the infection cyle include some highly 
antigenic proteins, such as 6 kDa early secreted antigenic target (ESAT-6) and antigen 85 
(Ag85), which are recognised by CD4+ T cells of almost all TB infected hosts (Andersen 
et al., 1993; Schwander 2000). IFN-γ producing CD27-CD4+ memory T cells have been 
identified in M. bovis- and Mtb- infected mice (Lyadova et al., 2004). Mtb is most 
commonly taken up into the macrophage phagosome, thus its antigens are usually 
presented via MHC II to CD4+ T cells. However, Mtb down-regulate expression of MHC 
II molecules on the surface of macrophages (Stenger et al., 1998; Noss et al., 2000). The 
reduced expression of MHC II molecules on the surface of macrophages is thought to be 
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a result of impaired IFN-γ stimulation in Mtb infection (Ting et al., 1999). However, DCs 
up-regulate molecules for antigen-presentation after infection with Mtb and this 
contributes significantly to the presentation of antigens to CD4+ T cells (Bodnar et al., 
2001).  
 
CD4+ T cells are essential for the controlling of Mtb infection in both mice and humans 
(Smith et al., 2000). Adoptive transfer of immune CD4+ T cells results in enhanced 
protection against Mtb in mice (Orme et al., 1984). HIV patients with loss of CD4+ T 
cells have a higher risk of developing active Mtb, emphasising the important role of 
CD4+ T cells in human Mtb infection (Flynn et al, 2001). 
 
Apart from secretion of IFN-γ to enhance the mycobactericidal ability of macrophage 
(see section 2.5.1), CD4+ T cells also act as CTLs. After in vitro stimulation with Mtb, 
up-regulation of  mRNA for granzyme A and B, granulysin and perforin is observed in 
CD4+ T cells and this is thought to help the killing of  Mtb-infected monocytes (Canaday 
et al., 2001).  In addition, CD4+ T cells are also critical in the development of cytolytic 
function of CD8+ T cells. Studies examining the function of CD8+ T cells in the absence 
of CD4+ T cells using a murine model show that although the IFN-γ production of Mtb-
specific CD8+ T cells does not decrease in vitro and in vivo, the expression of mRNA for 
IL-2 and IL-15 do decrease in Mtb-infected CD4-deficient mice, which results in 




2.2.2 CD8+ T cells 
Mtb-specific CD8+ T cells are found in alveolar spaces of healthy PPD+ people (Tan et 
al., 1997). They are present in the lungs and lung-draining lymph nodes (LNs) of mice 
infected with Mtb via the aerosol or intravenous route (Serbina et al., 2001). CD8+ T cells 
may be activated by cross-priming (see section 2.3), or via conventional MHC I 
presentation by infected macrophages. Mycobacterial lipids presented by CD1 molecules 
on DCs are also recognised by CD8+ T cells (Rosat et al., 1999; Vincent et al., 2003). 
Vesicles containing glycolipids can get access to DCs and are presented to CD1-restricted 
CD8+ T cells (Sugita et al., 2000). CD1a (in the early recycling endosome) and CD1c 
usually get access to mycobacterial glycolipids since Mtb prevents the maturation of 
phagosomes (Beatty et al., 2000).  
 
After activation, CD8+ T cells produce IFN-γ as well as TNF-α to activate macrophages 
(Flynn, 2004). However, the most important functions of CD8+ T cells are to lyse 
infected cells by secretion of perforin and granzymes or via the Fas/FasL-pathway. In 
humans, CD8+ T cells have also been demonstrated to kill intracellular bacteria directly 
by release of granulysin through the perforin pore (Cho et al., 2000).          
 
2.2.3 γδ T cells 
γδ T cells constitute about 5% of T cells in the peripheral blood in human adults and they 
also participate in the immune response against Mtb. γδ T cells are different from CD4+ T 
cells and CD8+ T cells in that they are readily activated by Mtb and can produce IFN-γ in 
the early stages of infection (Kaufmann, 1996). They also perform CTL function via 
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release of granules (Behr-Perst et al., 1999). The majority of γδ T cells proliferated 
against Mtb are found to be Vgamma9/Vdelta2 T cells. T cells that express γδ TCR in 
humans are stimulated by a unique group of antigens that contain phosphate, and antigen 
processing is not required by Vgamma9/Vdelta2 T cells (Sireci et al., 1997). They also 
produce granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-3, and TNF-α 
that are potential macrophages activators (De la Barrera et al., 2004). An overwhelming 
neutrophil influx is found in Mtb-infected mice lacking γδ T cells, but the control of Mtb 
infection is not impaired and survival is equivalent to wild-type infected mice. Thus γδ T 
cells were postulated to be able to promote influx of Th1 cells and monocytes, influence 
local cellular traffic and limit the access of inflammatory cells to ensure the normal 
formation of granulomas, but may not directly affect bacterial load (D'Souza et al., 1997).   
2.2.4 NK cells 
NK cells are thought to be important responders to Mtb infection because they proliferate 
against live Mtb in vitro (Esin et al., 1996). IFN-γ produced by NK cells, in response to 
TNF-α and IL-12, enhances the mycobactericidal activity of macrophages and promotes 
the development of Th1 responses. The secretion of IFN-γ by NK cells is independent of 
IL-2. NK cells kill the target cells at an early stage of BCG infection  (Esin et al., 2004). 
In addition, NK cells play a role in development of CD8+ CTLs. Human studies show 
that the production of IL-15 and IL-18 elicited by NK cells favours the maintenance of 




2.2.5 TB vaccines that can induce cytotoxicity 
Studies on the adoptive transfer of protection from ESAT-6-vaccinated or Mtb-infected 
mice into naïve mice by transfer of purified T cells have revealed that it is the antigen-
specific MHC I-restricted cytotoxic T cells that confer protection by producing IFN-γ and 
lysing infected macrophages (Lowrie et al., 1997; 1999). One currently favoured method 
to create a new TB vaccine that can induce protective CTL is by using a DNA 
vaccination strategy.  It is found that splenic T cells from mice immunised with 
recombinant adenovirus-based tuberculosis vaccine expressing Mtb Ag85 are capable of 
cytolytic activity. Upon transfer into lungs of naïve mice, they confer immune protection 
against Mtb challenge (Santosuosso et al., 2005). This shows that target cell cytotoxicity 
is an important mechanism for immune protection against Mtb, and strengthens the 
argument for seeking new vaccines with such activity. 
2.3 Antigen presentation pathways in Mtb infection  
T cells recognise Mtb antigens in the context of the antigen-presenting molecules MHC I, 
MHC II and CD1 (Kaufmann, 2001), and both DCs and macrophages are important in 
this regard. Mtb infection of DCs results in an increased expression of co-stimulatory 
molecules such as CD54, CD40, CD80 and CD86 in addition to MHC I, MHC II and 
CD1 on its surface (Henderson et al., 1997). Secreted Mtb antigens would be presented 
via the MHC Class II pathway to CD4+ T cells whereas intracellular Mtb antigens in the 
cytoplasm would be presented via the MHC Class I pathway to CD8+ T cells. 
 
Cross-presentation is recently recognised as an important alternative mechanism by 
which CD8+ T cells recognise Mtb antigens. The infection-induced apoptosis of host 
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cells, which are subsequently taken up by DCs, is considered to be the most likely 
scenario for Mtb cross-presentation (Schaible et al., 2003). Macrophage apoptosis could 
be caused by the pathogen itself or by host factors such as the accumulation of pro-
inflammatory cytokines (TNF-α) and direct killing by CTL and NK cells by either the 
Fas/ FasL- or perforin/granzyme-pathway (Chen et al., 2004). The lipoarabinomannan 
(LAM) and a 19 kDa lipoprotein of Mtb induce host apoptosis via Toll-like-receptor 2 
(TLR2). The microbial pathogen-associated molecular patterns (PAMPs) contained 
within the apoptotic bodies will bind to TLR and thus stimulate pro-inflammatory 
responses by inducing T cell cytokines, as well as DC maturation and migration to the 
draining  lymph nodes to activate mycobacterium-specific T cells (Lopez et al., 2003).  
 
Other proposed models of Mtb cross-presentation include the following. First, MHC I 
molecules could capture the peptides from exogenous antigens outside of the 
endoplasmic reticulum (ER) when these MHC I molecules are devoid of peptides or they 
are only binding with the invariant chain. Second, Mtb escapes from the phagosome to 
the cytosol so that the antigens of Mtb get presented with MHC I. Third, antigens in the 
phagosome, instead of going to MHC II presentation pathway, go through the MHC I 
processing and peptides loading pathway via transporter associated with antigen 
presentation (TAP). However, this last mechanism still requires the transfer of  peptides 
from phagosome to cytosol as mentioned in the second mechanism (Winau et al., 2004). 
In addition, soluble antigens of Mtb presented to human CD8+ T cells via an alternate 
MHC I processing which is not dependent on the classical processing machinery has also 
been suggested (Canaday et al., 1999). 
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Studies by Teitelbaum et al show that it is possible that the antigens of bacilli enter from 
phagosome into cytoplasm via the pores on the membrane (Teitelbaum et al., 1999). 
However, Denis et al show that in vitro stimulation of CD8+ T cells by cell culture filtrate 
from BCG was inhibited by chloroquine but not by brefeldin A or in the absence of 
transporter-associated protein (TAP)-2, suggesting that in this case, the antigen 
processing pathway does not involve the transfer of antigens from endosome to cytosol 
(Denis et al., 1999).  
 
2.4 Th1 and Th2 response 
Efficient clearance of aerosol-inhaled Mtb requires Th1 cells to secrete IFN-γ in order to 
facilitate the activation of the infected macrophages and enhance the killing of the 
bacteria inside (Saunders et al., 2000). It has been found that a higher ratio of Th1/Th2 is 
important in immune protection against Mtb (Lienhardt et al., 2002). Previous studies 
showed that membrane LAG-3, IL-12Rβ2, CCR5 and CXCR3 are associated with Th1 
cells, while CD62L, CD30, CCR3, CCR4, and CRTH2 are associated with Th2 cells. In 
addition, the IL-18 receptors and ST2L are selectively expressed on Th1 and Th2 cells, 
respectively, of circulating lymphocytes in humans (Chan et al., 2001). Mtb is known to 
induce many cytokines of Th1 and Th2 origin. It was reported that culture filtrate 
preparations, cell wall preparations and most immunogenic antigens of Mtb induced both 
Th1 and Th2 cytokines. However, certain antigens from Mtb preferentially induce either 
Th1 cytokines or IL-10 (Al-Attiyah et al., 2004).  
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2.5 Roles of cytokines in Mtb infection 
2.5.1 IFN-γ 
IFN-γ and TNF-α are found to be necessary in the early stages of induction of both 
murine CD4+ and CD8+ cytotoxic T cells by Mycobacterium leprae heat shock protein 
(hsp) 65 kD (Sasiain et al., 1998). IFN-γ secretion by NK cells early, and by activated 
lymphocytes (CD4+ T cells, CD8+ T cells and γδ T cells) later, in infection is required for 
killing activity of macrophages against intracellular Mtb (Bonecini-Almeida et al., 1998; 
Dillon et al., 1999). Activated macrophages achieve maturation of the phagosome and the 
production of antimicrobial molecules such as reactive oxygen intermediates (ROI) and 
nitrogen oxides. This IFN-γ secretion is also important in the inducing of IL-12 
production that will further enhance the Th1-like response to the intracellular pathogens 
(Ma et al., 1996). The synthesis of IFN-γ is thought to be regulated by IL-12, IL-18 and 
IL-23. However, studies in IL-12p40, IL-18 and IL-23 knockout mice indicate that there 
is IFN-γ production by T helper cells which is independent of these cytokines, as the 
knockout mice have protection comparable to wild type mice (Kawakami et al., 2004).  
In immune response to Mtb, IFN-γ is very important because both humans who lack the 
receptor of IFN-γ and mice that lack IFN-γ or its receptor have greater chance to be 
infected with Mtb (Collins et al., 1975). In peripheral blood mononuclear cells (PBMCs) 
derived from patients with moderate or advanced infection, adding exogenous IFN-γ 
restored the cytotoxic activity (de la Barrera et al., 2004).  However, the in vitro IFN-γ  
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production of T cells may not be directly correlated with the control of Mtb (Hoft et al., 
2002). 
2.5.2 TNF-α 
Tumor necrosis factor α (TNF-α) is produced by macrophages, dendritic cells and T 
cells. TNF-α induces inducible nitric oxide synthase (iNOS or NOS-2) expression in 
synergy with IFN-γ to enhance the killing of intracellular bacilli. It also promotes and 
maintains a normal granuloma compoistion in which the lymphocytes are co-localised 
with macrophages, by regulating the expression of adhesion molecules, chemokines and 
their receptors (Flynn, 2004). In addition, TNF-α is also thought to be involved in 
destructive pathology since it is found in the murine model that an unbalanced high level 
of TNF-α results in massive inflammatory response in the lung (Flynn, 2001). In 
addition, TNF-α is found to act co-ordinatedly with IFN-γ to induce cytotoxic CD4+ or 
CD8+ T cells in PBMCs of multibacillary leprosy patients (Sasiain et al., 1998). 
2.5.3 IL-4 
IL-4 produced by T cells act as antagonists to the effects of IFN-γ (Martinez et al., 1990;  
Jankovic et al., 2001).  CD4+ (Bhattacharyya et al., 1999) and CD8+ (Smith et al., 2002) 
T cells showed increasing IL-4 secretion in PBMCs from TB patients when stimulated 
with dead Mtb or live Mtb H37Ra. IL-4 gene-deleted mice show improved survival in 
Mtb infection, and reduced sensitivity to necrotic effects of TNF-α (Hernandez-Pando et 
al., 2004). Thus, IL-4 is believed to contribute to immunopathology in tuberculosis in 
both mice and humans.  
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2.5.4 IL-10 
IL-10 can inhibit a pro-inflammatory response. It suppresses the secretion of 
inflammatory cytokines and chemokines, deactivates the macrophage as well as natural 
killer cell activity.  IL-10 is also known for its immunosuppressive ability. It restricts T 
cell proliferation, dampens the activity of cytokines and causes the loss of the normal 
immune function of activated T cells, effector T cells or cytolytic T cells.  
 
The cytokines that are inhibited by IL-10 include IL-1, IL-3, IL-4, IL-2, IFN-γ, TNF-α, 
and granulocyte-monocyte colony stimulating factor (GM-CSF). IL-10 is also a 
‘macrophage deactivation factor’ because it abrogates the antigen presentation ability by 
down-regulating MHC class I and II molecules as well as co-stimulatory molecules such 
as CD86 and CD80, resulting in poor antigen-specific T cell-mediated macrophage 
activity. It also directly suppresses the microbicidal function of macrophages by 
inhibiting reactive oxygen and nitrogen intermediates production. The role of IL-10 in 
regulatory T cells is described in section 2.7. 
There is evidence to suggest that Mycobacterium tuberculosis, M. avium complex and M. 
leprae can stimulate macrophages to produce IL-10 (Maeda et al., 1995; Manca et al., 
1999; Othieno et al., 1999; Zhang et al., 1999;), which delays the mycobactericidal 
activity of macrophages, suppresses cytotoxic T cells and thus enhances their persistence 
within the host by preventing the apoptosis of infected cells (Muller et al., 1998; 
Yamamura, 1992). When PBMCs derived from healthy subjects were infected with 
Mycobacterium tuberculosis in the presence of IL-10, the killing ability of CD4+ T cells 
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and CD8+ T cells was suppressed but the lytic ability of γδ T cells was enhanced (de la 
Barrera et al., 2004).   
Transgenic mice which constitutively produce and secrete IL-10 are less capable of 
clearing BCG infection, although the level of IFN-γ production is comparable to wild 
type mice (Murray et al., 1997). However, IL-10 gene-deleted mice are not more resistant 
to acute Mtb infection compared to wild type mice (North, 1998).  
2.6 CD44+ T cells 
CD44 is an acidic sulfated membrane glycoprotein expressed in several alternatively 
spliced and variably glycosylated forms on many cell types including mature T cells. 
Recently-activated and memory T cells express higher levels of CD44 than do naïve T 
cells. The role of CD44+ T cells is to recruit other T cells to the site of inflammation. The 
migration of the T cells to the inflammatory sites requires integrins and other adhesion 
molecules. It was reported that CD44 is an adhesion receptor and it plays multiple roles, 
such as influencing the environment of cells that control the cells’ growth and 
differentiation. In particular,  CD44 plays a role in the extravasation of T lymphocytes 
(Ponta et al., 2003). 
 
CD44 gene-deleted mice have been invaluable in clarifying the role of CD44+ cells in 
infection immunity. One of these studies showed that introducing inflammatory material 
into lungs of CD44-/- mice leads to severe inflammation and lung-tissue damage 
compared with wild type mice (Teder et al., 2002). In a murine model of high-dose Mtb 
aerosol infection, CD44-/- mice have reduced ability to control Mtb growth compared 
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with wild-type mice (Leemans et al., 2003). Another murine model which uses a low-
dose Mtb airway infection shows that the bacterial load in lung or liver tissue is 
comparable to that of wild-type mice, except that there are more neutrophils in the lung 
tissue and alveolar spaces in CD44-/- mice (Kipnis et al., 2003). Nonetheless, both models 
show that CD44 plays some role in controlling the bacteria and in granulocyte formation 
in Mtb infection. 
 
In addition, memory/activated T cells induced by BCG or Mtb hsp65-DNA vaccination 
are found to be CD44hi, which affects long-term protection against Mtb infection (Silva et 
al., 1999). 
2.7 Regulatory T cells (Tregs) 
Tregs are CD4+ T cells that inhibit immunopathology or autoimmune disease in vivo. 
Two major Tregs populations have been described, which are naturally occurring Tregs 
and interleukin-10 secreting Treg cells (O'Garra et al., 2004 a). IL-10 Tregs can be 
induced under particular experimental conditions of antigenic stimulation in vitro and in 
vivo (Castro et al., 2000) or in natural infection in vivo (Belkaid et al., 2001). IL-10 Tregs 
inhibit the proliferation of naïve CD4+ T cells via a cell-cell contact-dependent 
mechanism in both mice and humans (Thornton et al., 1998; Shevach et al., 2002), which 
is probably mediated by cell-surface-bound TGF-β (Nakamura et al., 2001). Tregs may 
function via the action of IL-10 (Asseman et al., 1999), cytotoxic T lymphocyte-
associated protein 4 (CTLA4) (Read et al., 2000) and/or TGF-β (Maloy et al., 2001).  
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IL-10 is produced by both antigen-driven IL-10 Tregs and other T cells, including Th1 
cells, naturally occurring Tregs and CD8+ T cells (O'Garra et al., 2004 b), and in some 
cases, macrophages (McGuirk et al., 2002) and B cells (Fillatreau et al., 2002). The 
naturally-occurring suppressor CD4+ T cells and the antigen-driven IL-10-producing 
regulatory CD4+ T cells are the most prominent cell populations. Tregs inhibit T cell 
expansion in vivo (Sundstedt et al., 2003) and influence the cytokine milieu (Ramsdell, 
2003; Maloy et al., 2001). IL-10 is known to be able to suppress TNF-α production 
(Moore et al., 2001). IL-10 secreting Tregs are found in TB patients in Cambodia who 
show persistent anergy to PPD. That anergy to PPD is antigen-specific, and characterised 
by impaired T cell proliferative responses and reduced levels of IL-2 in response to PPD 
(Delgado et al., 2002).  Another study shows that in anergic TB patients, IL-10-producing 
T cells are constitutively present. They are induced by Mtb antigen in vivo and inhibit 
immune responses to Mtb (Boussiotis et al., 2000).      
 
2.8 Environmental mycobacteria 
The main human pathogens in the Mycobacterium genus are M. tuberculosis and M. 
leprae and these are obligate intracellular bacteria. However, there are numerous 
Mycobacterium species which are free-living in the soil and open waters, and thus are 
known as environmental mycobacteria (Env) or sometimes termed non-tuberculous 
mycobacterium (NTM) species. Many Env are potentially pathogenic, and have been 
reported to be involved in human and animal diseases.  Apart from disseminated and 
localised diseases in immunocompromised patients, the most frequent infections in 
immunocompetent people involve the lungs, skin, and, in children, cervical lymph nodes 
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(Wayne et al., 1992; Tortoli et al., 2003). However, compared to tuberculosis, these 
diseases are relatively very uncommon in the clinical setting for immunocompetent 
people, although it is possible that asymptomatic colonisation may occur.  
2.8.1 Classification of environmental mycobacterium 
The first classification of Mycobacteria was proposed by Timpe and Runyon in the 
1950s, based upon growth rate and pigment production (Timpe et al., 1954) (Table 2.1). 
Based upon whether the bacteria require more or less than 7 days to grow on agar, slow-
growers (group I, II and III) and fast-growers (group IV) are distinguished. Group I, II 
and III Env are further distinguished by pigment production. Group I Env only produce 
pigment when grown in the light, thus they are called photochromogens. They include 
pathogens such as M. kansasii, M. marinum and less common Env such as M. simiae and 
M. asiaticum. Group II Env produce pigment even without exposure to light, and are 
known as scotochromogens. They include M. scrofulaceum, M. szulgai and 
nonpathogenic M. gordonae and M. flavescens. Group III Env are not strongly pigmented 
under any condition. Thus they are called nonphotochromogens. They include M. avium-
intracellulare (also known as M. avium complex, MAC), M. xenopi and M. terrae. Group 
IV fast-growing Env include pathogens such as M. fortuitum and M. chelonae and 











Table 2.1:  Runyon classification of mycobacteria by speed of growth and pigment 
production (Timpe et al., 1954). 
 
2.8.2 Phylogeny of Mycobcateria 
16S rRNA sequencing is the most established way of determining phylogenetic 
relationships in the Mycobacterium genus. 16S rRNA homology values of ten Env are 
shown in Table 2.2 and the phylogenetic tree for the genus is illustrated in Fig. 2.1. Slow- 
growers are phylogenetically distant from fast-growers within the genus. For example, 
slow-growing species like M. avium, M. scrofulaceum and M. kansasii are closely 
related, with 16S rRNA sequence homology values of about 99%. Homology values 
between M. marinum, M. gordonae or M. terrae and M. avium are lower, at 
approximately 96%. The homology values between fast-growers like M. chelonae and M. 
Slow growing mycobacteria 
  




little or no pigment when grown in dark 
bright yellow, orange or red when grown 
in light 




Group II  
Scotochromogens   yellow or orange when grown in dark 
M. scrofulaceum, M. 
avium, M. szulgai, M. 
gordonae 
     
Group III 
Nonphotochromogens   no pigment production 
MAC, M. xenopi, 
M. terrae, M. 
malmoense, M. 
ulcerans 
   
Fast growing mycobacteria 
 
Group IV   pigmentation variable 
M. fortuitum,M. 
smegmatis, M. chelonae
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avium are even lower, at about 94% (Wayne et al., 1992). In spite of the apparent relative 
distances, members of the Mycobacterium genus, compared to most other bacterial 
genera, have an extremely high degree of gene conservation. This is important in 
consideration of cross-reactive responses in immune responses between different 
members of the genus.  
 
 






Table 2.2   Homology values (%) of 16S rRNA from ten Env species studied in this 
thesis. Extracted from: Rogall et al., 1990. 
  avi for gor kan mar scr sme szu ter che bovis 
avi  95 98 99 98.6 99.4 95 99.1 96.6 95 98.6 
for   95.4 95.1 95.9 94.9 97.9 95.2 94.4 99 95.7 
gor    98.1 97.9 97.9 95.5 98.2 97.3 95.3 97.8 
kan     98.7 99 95.1 99.3 96.7 95 98.8 
mar      98.5 95.4 98.7 97.5 95.6 99.4 
scr       95 98.7 96.2 95.3 98 
sme        95.2 96.4 97.4 95.5 
szu         96.8 94.6 98.9 
ter          96.1 97.5 
che                      95.4 
 Fig. 2.1 Phylogenetic tree showing the phylogenetic relationships 
of species belonging to the genus Mycobacterium. Arrows 
indicate the species which are either investigated in this project or 
alluded to significantly in the text. (From Tortoli, 2003) 
 
MSR = M. simiae related; MTR = M. terrae related; SG = slow 





2.8.3 Immune responses to environmental mycobacteria (Env) 
Some of the Env are recognised to be quite immunogenic in murine infection models. 
They are able to induce pro-inflammatory cytokines such as IL-6, IL-1 and TNF-α in the 
host (Bradbury et al., 1990; Denis et al., 1994).They are also known to have the ability to 
activate cells to produce nitric oxide synthase-2 (NOS2) (Moncada, 1993) and reactive 
oxygen species (ROS) (Fridovich et al., 1995). 
 
Differences in the ability to induce pro-inflammatory factors have been shown in murine 
macrophages infected in vitro with M. avium, M. terrae and M. scrofulaceum. M. terrae 
BA 26 has better ability to induce pro-inflammatory factors and cytotoxicity in 
macrophages compared to M. avium and M. scrofulaceum (Huttunen et al., 2000). In M. 
avium-infected mice, while CD4+ T cell confer protection, CD8+ T cells are found to have 
limited role in immune defence (Appelberg et al., 1992). The severe apoptosis of CD8+ T 
cells at early stage of M. avium infection is proposed as one reason why CD8+ T cells fail 
to have protective role in the infection (Roger et al., 2001). γδ T cells are also not 
involved in immune protection against the M. avium infection (Petrofsky et al., 2005).  
2.9 Effect of pre-exposure to Env on subsequent BCG vaccination 
The live attenuated Mycobacterium bovis strain bacille Calmette-Guérin (BCG) is the 
only available human vaccine against TB. In Singapore, all newborn babies are given this 
vaccine. However, this live BCG vaccine has variable efficacy in humans. It has minimal 
or no protection at all in certain high TB incidence regions, but good protective efficacy 
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in children in the UK and France (Fine, 1989; Calmette et al., 1929). Although the 
reasons for this variability are still poorly understood, there are several postulations. A 
notable hypothesis relates to differential prior exposure to Env (Fine, 1989). Orme et 
al performed the first mouse model that showed the BCG vaccine does not protect mice 
which are pre-sensitised with Env (Orme et al., 1986). In guinea pigs, pre-sensitisation 
with Env provided a low level yet efficient protection. The vaccination of pre-sensitised 
guinea pigs with BCG failed to give them further protection (Palmer et al., 1999; de Lisle 
et al., 2005; Brandt et al., 2002). This phenomenon is also observed in a cattle 
experimental model (Buddle et al., 2002).  
 
Several studies in humans regarding the effects of Env have been conducted by Black et 
al. It has been observed from BCG vaccine trials that vaccinated young adults did not 
have significantly different TB incidence upn follow-up, relative to non-vaccinated adults 
in northern Malawi. In this population, in vitro PBMC IFN-γ responsiveness was highest 
for PPDs of M. avium, M. intracellulare, and M. scrofulaceum (the MAIS complex), 
which correlates with the known presence of these genetically-related mycobacterial 
species common in Malawi. After vaccination, the BCG-attributable increase in IFN-γ 
response to M. tuberculosis PPD was greater for individuals with low initial 
responsiveness to MAIS antigens than for those with high initial responsiveness. Thus, it 
is possible that prior exposure to environmental mycobacteria interferes with immune 
responses to BCG vaccination in people living in northern Malawi (Black et al., 2001a). 
A parallel study was conducted in the UK, where human subjects were less exposed to 
MAIS antigens (low frequency of response to Env PPDs), and BCG vaccination was 
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highly effective in protecting against TB. IFN-γ and delayed-type hypersensitivity (DTH) 
responses to PPD increased more in the UK than in Malawi one year post-vaccination, 
whereas the pre-vaccination IFN-γ production and DTH responses in Malawi were higher 
than those in the UK (Black et al., 2001b). 
 
The two studies conducted by Black et al provide circumstantial evidence that pre-
exposure to Env may be related to subsequent effectiveness of BCG vaccine in humans. 
Brandt et al investigated the mechanism behind it in a mouse model. Six different isolates 
of Env from soil and sputum samples from the Karonga district in northern Malawi were 
studied. Interestingly, they found that in Env-sensitised mice, BCG induces only a 
transient immune response with a low frequency of mycobacterium-specific cells and no 
protective immunity against TB. Two strains of the Mycobacterium avium complex 
even inhibited BCG activity completely, by reducing the proliferation of BCG in vivo 
(Brandt  et al., 2002). These studies form the basis for the current work described in this 
thesis, which focuses on the mechanisms involved in cellular responses to Env and how 






CHAPTER 3  MATERIALS AND METHODS 
3.1 Bacterial species 
Ten environmental mycobacterium (Env) species, namely, Mycobacterium avium (avi), 
M. fortuitum (for), M. gordonae (gor), M. kansasii (kan), M. marinum (mar), M. 
scrofulaceum (scr), M. smegmatis (sme), M. szuglai (szu), M. terrae (ter), and M. 
chelonae (che), derived from clinical samples cultured on Lowenstein-Jensen media, 
were a generous gift from Dr Pam Nye, University College London Hospitals (UK). 
Mycobacterium bovis BCG (Pasteur) vaccine strain was donated by Dr William Jacobs, 
Jr (Albert Einstein College of Medicine, USA). All species were subsequently cultivated 
in Middlebrook 7H10 agar, supplemented with oleic acid-albumin-dextrose-catalase 
(Difco), and single colonies picked for growing in Middlebrook 7H9 broth (Difco) before 
storage as glycerol stocks at -80°C.  
3.2 Mycobacterial antigens preparation 
Env whole cell lysates used in this project for stimulation of cells were previously 
prepared by a lab colleague. Briefly, the ten Env species were grown to mid-log phase in 
Sauton’s protein-free medium. After washing thrice with 50 ml PBS at 2500 x g for 10 
min at 4 °C, the cell pellets were collected and added to tubes containing protease 
inhibitor cocktail (BD Biosciences) and 0.1 mm heat-sterilised zirconia/silica beads 
(Biospec Products). The tubes were then vigorously agitated in a Mini Beadbeater 
(Biospec Products) for 5 rounds of 1 min at 5000 rpm, resting on ice for 1 min between 
cycles. The cells were then centrifuged at 13000 x g for 10 min at 4 °C and the 
supernatant filter-sterilised using a 0.45 μm filter. There was no detectable 
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lipopolysaccharide in the lysates. The protein concentration was then measured via the 
Bradford protein assay using the BioRad DC Protein Assay kit, and the lysates stored at -
20°C before use. 
3.3 Other antigens used 
Purified protein derivative of M. tuberculosis (MTB) was purchased as PPD RT23 from 
Statens Serum Institute (Denmark) and used at a final concentration of 1 μg/ml  for cell 
stimulation, as it contains the crude protein antigens of MTB thus it was used as a 
comparator antigen preparation to Env lysates. Streptokinase-streptodornase (SKSD) 
(Varidase Topical, CV Laboratories, Hants, UK) at a working concentration of 250 μg/ml 
was an irrelevant (non-mycobacterial) antigen control. The diluent used for the Env 
lysates was nanopure water, this was used in equivalent volume as a negative control 
(unstimulated wells) when Env lysates were used for cell stimulation. The mitogen, 
phytohaemagglutinin (PHA) (Sigma), was used as a positive control at 1 μg/ml for cell 
stimulation. In certain experiments, heat-killed mycobacteria were used as antigenic 
stimulation. 
3.4 Preparation of heat-killed and live mycobacterial cultures 
M. avium, M. smegmatis, M. chelonae and M. bovis BCG were grown in roller bottles, 
and about 20ml of mid-log cultures were centrifuged at 2500 x g for 10 min at 4 ºC. The 
supernatant was discarded and cell pellet washed twice with in 10 ml sterile PBS 
(prepared with nanopure water) before re-suspension in a final volume of 3 ml. This 
bacterial suspension was passed via a syringe through a 27 G needle to reduce clumping, 
before measuring absorbance at 600 nm to estimate bacterial numbers (1 A600 ~ 2x108 
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bacteria). Either 100 μl of 1x 106cells (for murine immunisation) or 50 μl of 1x 107 cells 
(for lymphocyte restimulation in cytotoxicity assay) or 10 μl of 1x 106 cells (for 
lymphocyte restimulation in proliferation assay) in sterile PBS were heat-killed at 95ºC 
for 15 min, and stored at -20 ºC before use. For intranasal live BCG infection of mice, 
1.25x 105 live BCG were re-suspended in10 μl PBS and kept at 37 ºC prior to injection. 
3.5 Human donors 
This study included 10 healthy adult donors, aged between 21 – 45 years. All were BCG-
vaccinated 9 – 20 years previously, and had no prior known exposure to tuberculosis. 
They did not have latent tuberculosis, as evidenced by negative IFN-γ response of their 
PBMCs to ESAT-6 and CFP-10 which are Mtb-specific proteins not found in BCG. 
Informed consent was obtained from all donors and the human study was approved by the 
institutional review board.  
3.6 Isolation of Human PBMCs 
Ten millilitres of venous blood were collected in heparinised tubes. Peripheral blood 
mononuclear cells (PBMCs) were isolated within 30 min after collection by 18 min 
density gradient centrifugation through Ficoll-Paque Plus (Amersham). To remove blood 
platelets, 2 ml of foetal calf serum (FCS, Biological Industries) per tube was layered 
below the RPMI-cell suspension and centrifuged at 200 x g for 15 min. The number of 
cells isolated was determined using a haemocytometer, and viable counts determined by 
the trypan blue exclusion assay. 
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3.7 Trypan Blue Exclusion Assay 
To count the viable cells, 20 μl of cells were resuspended mixed with 20 μl of the 0.04 % 
trypan blue dye (Merck) at room temperature for 3 min. Subsequently, 10 μl of the cell 
mixture was loaded into a single chamber of a haemocytometer for cell counting. Non-
viable cells were stained blue because of their inability to limit the entry of the blue dye, 
while viable cells remain clear.  
3.8 Mice  
Specific pathogen-free male BALB/c mice between 5 – 6 weeks old were obtained from 
Animals Centre. Mice were maintained in the departmental animal facility, housed in 
individual isolator cages (Alternative Design) with filter tops. Food and water were 
supplied ad lib, and beddings were changed twice a week.  
3.9 Preparation of murine splenocytes 
The mice were sacrificed by CO2 asphyxiation at appropriate time points. After sterile 
dissection of the spleen, splenocyte suspensions were collected in 4 ml of RPMI + 5 % 
FCS after mashing the organ through a sterile 40 μm nylon cell strainer (BD Falcon). 
After centrifugation at 350 x g for 10 min, the supernatant was discarded and 1 ml of 0.17 
M NH4Cl was added for 20 sec to lyse the red blood cells. The cells were immediately 
diluted in an additional 5 ml of RPMI, centrifuged at 350 x g for 10 min, supernatant 
discarded and cells resuspended in RPMI.  
 
B cells were depleted using Dynabeads Mouse pan B (B220) (Dynal Biotech ASA, Oslo, 
Norway) according to the manufacturer’s instructions. Briefly, splenocytes were stained 
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with anti-CD19 linked to magnetic beads, in RPMI+ 5 % FCS for 30 min at room 
temperature. Magnetically-linked B cells are attracted to the side of the tube after placing 
the tube onto a magnetic separator (Miltenyi Biotec). Non-labelled cells were removed, 
the B cell-depleted splenocytes were seeded in 60 mm Petri dishes (Greiner) in 5 ml 
RPMI + 5 % FCS overnight, and cell numbers enumerated on the following day. All 
experiments utilising murine splenocytes were derived following this treatment. 
3.10 Colorimetric lymphocyte proliferation assay  
3.10.1 Cell stimulation conditions 
All cell-antigen cultures were incubated at 37°C in humidified air containing 5% CO2 for 
4 days. Freshly isolated PBMCs or murine splenocytes were seeded at a cell density of 1 
x 105 in 200 μl of phenol red-free RPMI (Invitrogen Corporation) supplemented with 2 
mM L-glutamine and 5 % FCS in 96-well round-bottom tissue culture plates (Nunc, 
Denmark). Cells were then incubated with Env lysates or purified protein derivative 
(PPD) at concentrations of 1 μg/ml, 10 μg/ml and 20 μg/ml in order to determine the 
minimum antigen concentration required for optimal cell stimulation. The final 
concentration of Env lysates and PPD used for cell stimulations was 1 μg/ml because the 
higher concentrations did not cause increased cell proliferation. In experiments where 
heat-killed Env were used instead of lysates as the antigen preparation, the bacteria were 
added at a 10:1 ratio to the cells.  
3.10.2 Lymphocyte proliferation assay kit 
Proliferative response to different antigens was measured by a colorimetric assay using 
CellTiter 96® Aqueous Non-radioactive Cell Proliferation Assay Kit (Promega). The 
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assay kit is composed of a mixture of a novel tetrazolium compound 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
inner salt (MTS), and an electron coupling reagent (phenazine methosulfate; PMS). MTS 
is reduced by proliferating cells into a formazan product that is soluble in tissue culture 
medium. The absorbance of the formazan at 490 nm is then read. This is directly 
proportional to the number of proliferating cells in culture. 
 
After 4 days of antigen stimulation, cells were re-suspended gently, and 100 μl of cell 
suspension added to 20 μl of MTS/PMS from the assay kit for 8 hrs incubation (37°C, 
5% CO2). The colour change was measured by the Magellan ELISA Reader (Tecan) and 
proliferation was expressed as a stimulation index (SI) calculated by 
Absorbance of wells with antigens-Absorbance of culture medium______ 
Absorbance without antigens (unstimulated cells)-Absorbance of medium 
 
3.11 Detection of IFN-γ  by ELISA    
IFN-γ  production in culture supernatants was measured by enzyme-linked 
immunosorbent assay (ELISA), using the OptEIA human IFN-γ set (Pharmingen) 
according to the manufacturer’s instructions. Briefly, this was a sandwich ELISA using 
specific affinity-purified monoclonal antibodies against human IFN-γ. The capture 
antibody was coated in the wells overnight and 100 μl of supernatant added for 2 hours of 
incubation. Biotinylated anti-human IFN-γ antibody was used as the detecting antibody. A 
standard curve was generated with known amounts of recombinant human IFN-γ. The 
absorbance was read at 450 nm using a plate reader (Magellan ELISA Reader, Tecan) and 
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the amount of secreted IFN-γ in the samples was derived by interpolation from the 
standard curve. The detection limit of the assay was 4.0 pg/ml. By an unbiased rank 
assignment cut-off criterion, IFN-γ levels that were 4 standard deviations above the mean 
concentration in all unstimulated wells was considered a positive result. This cut-off 
value was found to be 40 pg/ml.  
3.12 Cytotoxicity assay 
3.12.1 Principles of assay  
Cytotoxic responses following antigen stimulation were measured using a non-
radioactive CytoTox 96® Assay kit (Promega). The CytoTox 96® Assay quantitatively 
measures lactate dehydrogenase (LDH), a stable cytosolic enzyme that is released upon 
cell lysis. The conversion of a tetrazolium salt (INT) into a red formazan product by LDH 
released in culture supernatants was measured with a 30 min coupled enzymatic assay. 
The amount of red formazan is proportional to the amount of LDH released, hence it is 
proportional to the number of lysed cells. The amount of the formazan was measured at 
490 nm, with the reference wavelength at 650 nm. The percentage cytotoxicity was 
calculated as: 
% Cytotoxicity = (Experimental – Effector Spontaneous – Target Spontaneous) × 100) 
           Target Maximum – Target Spontaneous 
 
3.12.2 Cytotoxicity assay experimental set-up 
Freshly isolated PBMCs were seeded in triplicates at 5 x 105 in 200 μl of complete media 
(RPMI 1640 supplemented with 2 mM L-glutamine, 5% FCS), in 96-well round-bottom 
tissue culture plates. The adherent cells after overnight culture were used later as target 
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cells, whereas the non-adherent cells were added to 1 x 106 PBMCs for antigen 
stimulation, in a final volume of 2.5 ml (effector cells). In murine cytotoxicity assays, 
splenocytes were seeded at 7.0 × 105 cells per well to generate target (adherent) cells and 
1 x 106 splenocytes used for antigen stimulation to generate effector cells. 
 
After 5 days of antigen stimulation, non-adherent effector cells were harvested for 
viability count, and the culture media replaced with fresh RPMI 1640 supplemented with 
2 mM L-glutamine + 2% FCS+ ferric ammonium citrate (FAC) at a working 
concentration of 50 μg/ml. At the same time, the target cells were infected with M. bovis 
BCG at an infection ratio (MOI) of 10:1, with added FAC at a working concentration of 
50 μg/ml to enhance intracellular mycobacterium growth. After 4 hours of infection, the 
extracellular bacteria were removed by gently aspirating the supernatant and washing the 
wells once with fresh complete media. The effector and target cells were then co-cultured 
at an effector-target ratio of 10:1 and the entire plate was centrifuged at 250 x g for 4 min 
to allow maximum contact between the effector cells and target macrophages. After 12 
hours of co-culture, the plate was again centrifuged at 250 x g for 4 min to obtain the 
cell-free supernatant. Certain control wells were also set up – effector cells added to wells 
without target cells (‘Effector Spontaneous’), target cells without effector cells (‘Target 
Spontaneous’), and target cells vigorously scraped off the plate, subjected to freeze-
thawing for 10 sec to lyse cells completely (‘Target Maximum’).  
 
Fifty microliters of supernatant was transferred into 96-well flat-bottom tissue culture 
plates (Nunc, Denmark) and 50 μl of reconstituted substrate mixture from the assay kit 
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were added to each well for 30 min incubation at 37 °C. Thereafter, 50 μl of stop solution 
was added. Intensity of colour change in individual wells was measured using the 
Magellan ELISA Reader (Tecan) at 490 nm with reference wavelength at 650 nm and the 
% cytotoxicity was calculated according to the formula given above.  
3.12.3 Cytotoxicity assay with IFN-γ blocking 
In experiments where it was required to block IFN-γ secreted by the effector cells, final 
concentration of 1 μg/ml recombinant IFN-γ  Receptor 1 (R&D Systems) was added at 
the same time when effector cells were stimulated with Env lysates. 
3.13 Positive and negative cell selection using magnetic beads 
For some experiments, cells bearing certain surface markers were depleted, using 
magnetic bead coupled antibodies, prior to performing the cytotoxicity assays. Before the 
co-culture of the effector and target cells, effector cells were pre-incubated with 
microbeads linked to antibodies against CD4,CD8, γδ-TCR or CD56 (Miltenyi Biotec) 
for 15 min at 4°C in dark in staining buffer according to the manufacturer’s instructions. 
Following processing through the AutoMACS (Miltenyi Biotec) selection column, 
magnetically-labelled cells were selected out using the ‘depletion sensitive’ mode. The 
non-labelled cells (negatively selected) were eluted for co-culture with target cells.  
 
In other experiments, it was desired to positively select either CD4+ or CD8+ T cells from 
murine splenocytes before performing flow cytometry. The cells were incubated with 
CD4 or CD8 antibodies linked with microbeads the same as above and the positively 
labelled cells were eluted using the ‘positive selection’ mode in the AutoMACS.  
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3.14 Flow cytometry  
3.14.1 Cell surface markers 
Cells designated for flow cytometry were PBS-washed and 5 x 105 cells per tube re-
suspended in 50 μl staining buffer (PBS containing 0.5% bovine serum albumin (BSA) 
(Sigma)). Two microliters of individual antibodies were added per tube and incubated for 
30 min at 4°C in the dark. Un-bound antibodies were then removed by washing with PBS, 
fixed with in 2% paraformadehyde and kept at 4°C in the dark before analysis. Cell 
surface marker expression was analysed by flow-cytometry (Cytomics FC500, Beckman 
Coulter). Fluorescence was analysed by gating on lymphocytes according to their 
characteristic forward scatter and side-scatter profile and measuring fluorescent intensity 
of the fluorochromes used, i.e. fluorescein isothiocyanate (FITC), phycoerythrin (PE), 
phycoerythrin-cyanate 5 (PE-Cy5) or phycoerythrin-cyanate 7 (PE-Cy7). 
       
Human PBMCs used for flow cytometry were cultured and antigen-stimulated in 500 μl 
of 1 x 106 cells per well in 48 well plates and non-adherent cells harvested for flow 
cytometry after 5 days. The first set of anti-human antibodies used was: CD4-FITC, 
CD8-PC5, CD3-PC7(Beckman Coulter), γ/δ TCR-PE (BD Biosciences), with respective 
isotype controls IgG1κ-FITC, IgG1κ -PC5, IgG1-PC7, IgG1κ -PE. The second set of anti-
human antibodies used was: IL-18R-PE, ST2L-FITC (R&D), CD56-PC5, CD3-PC7 
(Beckman Coulter), with isotype controls IgG1-PE, IgG1-FITC, IgG1-PC5, IgG1-PC7.  
      
For murine splenocyte experiments, generally 5 x 105 cells were used per tube for flow 
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cytometry. Anti-mouse antibodies used were: CD4-FITC, CD8-PE, with isotype controls 
IgG1 κ-FITC, IgG1 κ -PE and CD44-APC, CD45RB-PE, with isotype controls IgG1 κ -
PE, IgG1κ -APC (all from BD Biosciences). 
3.14.2 Intracellular cytokine staining 
Murine splenocytes were seeded at 2 x 106 cells per well in 24 well flat-bottom tissue 
culture plates. Heat-killed Env were added, at a bacteria-cell ratio of 1:1 for a 3 day 
incubation period. A final concentration of 3 μM monensin (Sigma) was added to the 
culture 4 hrs before harvesting. MACS positively selected cells (5 x 105 cells per tube) 
were collected for concurrent intracellular IL-10 staining and detection of cell surface 
expression of CD45RB. The set of anti-mice antibodies used were: IL-10-APC, 
CD45RB-PE, with isotype controls IgG1κ -PE, IgG1κ -APC (BD Biosciences). Cells 
were stained with CD45RB-PE in 50 μl staining buffer for 15 min at 4°C in dark before 
100 μl fixation buffer (buffer A) of Fix & Perm kit (Caltag Laboratories, USA) was 
added for a 15 min at 4°C. After washing with 2 ml cold staining buffer, cells were 
stained with IL-10-APC in 100 μl permeabilisation buffer (buffer B) from the same kit 
described above for 30 min at 4°C in dark. Cells were then washed with 2 ml cold 
staining buffer and fixed with 2% paraformadehyde and kept at 4°C in the dark before 
analysis. 
3.15 Murine immunisation and live BCG challenge 
For mycobacterial antigen immunisation, heat-killed mycobacteria, prepared as described 
above, were injected into the mice via the intraperitoneal (i.p.) route, using 1 x 106 killed 
bacteria in 100 μl sterile PBS, at weekly intervals for 3 or 4 weeks. One week after last 
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immunisation, the mice were either sacrificed for immunological studies or challenged 
with BCG by intranasal delivery of 1.25 x105 live BCG grown to mid-log phase and re-
suspended in 10μl PBS. The infected mice sacrificed after three weeks. To confirm the 
dose of BCG given, dilutions of the innoculum were plated on agar and colonies 
observed after 3 weeks of incubation at 37°C.   
 
3.16 Bronchoalveolar lavage (BAL) 
Following BCG challenge, to determine the extent of inflammatory cell infiltration in the 
lungs upon sacrificing the mice, BAL was performed. The thoracic cavity was opened, 
trachea exposed and lungs washed with 500 μl ice-cold PBS by instillation through a 1 
ml syringe. Cells obtained were centrifuged at 600 x g for 5 min and the supernatant 
stored at -20 ºC prior to cytokine determination. Cells were re-suspended in 150 μl RPMI 
and concentrated onto a single spot on glass slides at 550 rpm for 5 min, using the 
Cytospin 3 (Shandon, Fisher Scientific). The slides were stained with Giemsa 
(Applichem). The numbers of macrophages, neutrophils, lymphocytes and eosinophils 
were counted, and their adjusted numbers in 1ml of bronchoalveolar lavage fluid (BALF) 
was calculated.    
3.17 Colony counting 
Lungs were subjected to enzymatic digestion using 100 U collegenase D (Sigma) for 1 
hr. They were then homogenised in 1 ml Middlebrook 7H9 broth by mashing the organs 
through a 40 μm sterile nylon cell strainer (BD Falcon). The cell suspension was briefly 
subjected to low frequency sonication to disperse the bacteria. The cells from 
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homogenised organs were suspended in 1 ml RPMI with 100 U collegenase D and the 
sealed tube placed in a cup-horn sonicator (Sonics Vibracell VCX 500) for pulse 
sonication 3 times at amplitude of 60%. Several tenfold broth dilutions were plated on 
Middlebrook 7H10 agar on 60mm Petri dish in triplicates. Colony-forming units (CFU) 
were determined after 3 - 4 weeks of growth at 37 ºC.  
3.18 Cytokine measurements 
IFN-γ , IL-2, IL-10, IL12 (p70) and IL-4 production from fresh murine BALF and human 
IL-4, IL-6, IL-10, IL-12 (p70) and TNF-α from PBMC culture supernatants were 
measured using the Bio-plex cytokine reagent kit (Bio-Rad) according to the 
manufacturer’s instructions. Briefly, antibodies against certain cytokines, which were 
coupled to colour-coded 5.5 μm beads, were first allowed to react with the samples or 
with standard solution containing a known amount of cytokines. After performing 3 
rounds of washing to remove unbound protein, a biotinylated detection antibody was 
added to the beads. The reaction mixture was detected by the addition of streptavidin-
phycoerythrin (streptavidin-PE), which binds to the biotinylated detection antibodies. 
This is an automated multiplex bead-based plate assay that is able to quantify multiple 
cytokines in a small volume of sample. The results were read on the Bio-Plex system 
(Bio-Rad). 
 3.19 Statistical analysis     
Means of triplicate assays were compared using a two-tailed Student t test. Median 
results from groups of human subjects were compared using the non-parametric Mann-
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Whitney U test. The differences between groups were considered statistically significant 




CHAPTER 4  PATTERN AND NATURE OF HUMAN T CELLS 
RESPONDING TO ENVIRONMENTAL MYCOBACTERIA 
4.1 Introduction 
Environmental mycobacteria (Env) are ubiquitous in the environment, and constant 
human exposure through contact with soil and water is expected, even in an urban 
population (Fine, 1995). It is evident from the studies by Black et al (Black et al., 2001) 
that within a normal healthy human population, there is a diverse range of immune 
experiences with respect to Env. This prior sensitisation may have a profound influence 
on the way each individual responds to BCG vaccination, and to subsequent M. 
tuberculosis exposure. The aims of the work described in this chapter are to characterise 
the nature and diversity of Env responses in the local population and to determine if 
divergent Env responses are associated with differential anti-tuberculosis responses.  
 
Based on a cohort of local healthy human volunteers with prior BCG vaccination, we 
investigated: 
a. Patterns of lymphoproliferative responses and cytokines production against whole-
cell lysates of a panel of ten Env species 
b. Expansion of different immune cell types in response to Env 
c. Env-induced cytotoxicity against BCG-infected autologous macrophages  
d. T cell subsets responsible for Env-specific cytotoxicity  
e. Role of IFN-γ in Env-specific cytotoxic activity           
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4.2 Human proliferative response against Env 
To investigate the presence of the Env-responding lymphocytes, proliferation of PBMCs 
from ten healthy BCG-vaccinated human subjects in response to a panel of lysates 
derived from ten Env species was determined. The PBMCs were stimulated for 4 days 
with sterile nanopure water (negative control), or PPD (whole M. tuberculosis crude 
antigen preparation - positive control), or PHA (mitogen control), or one of the ten Env 
lysates (avi, for, gor, kan, mar, szu, scr, sme, ter, che) (Fig.1). Proliferative responses 
were expressed as stimulation index (SI, see Methods for derivation).  
 
Figure 1 shows the stimulation index for ten Env lysates and PPD, which ranged from 
1.409 to 1.825. The majority of Env lysate-stimulated cells gave significantly higher 
proliferation compared with non-stimulated cells for all the donors. This suggests that 
there was a significant presence of Env-responding memory T cells in the human 
subjects. The median SI for the ten Env lysates were not markedly disparate, suggesting 
that these species of Env lysates share a lot of common antigens. 
 
Based on figure 1, among ten Env lysates, M. avium, M. terrae, M. fortuitum induced 
highest proliferative responses, with stimulation index of 1.825, 1.818 and 1.809 
respectively. The proliferative responses did not differ between these three environmental 
mycobacteria. The four species that induced lowest proliferative response were M. 
gordonae, M. kansaii and M. marinum. The stimulation indices were 1.559, 1.470 and 
1.409 respectively. The rest of the Env species studied (M.  smegmatis, M. chelonae, M. 
szuglai, M. scrofulaceum) induced moderate proliferative responses. Surprisingly, in spite 
 42
of the previous BCG vaccination histories of all donors, PPD induced lower proliferative 
response than most Env lysates, and was higher than only three species. However, only 
M. terrae induced significantly higher proliferative response than PPD (p= 0.031). 
 
Species which induced best proliferation in the cohort (M. avium, M. terrae) and M.  
smegmatis, which induced moderate proliferation, gave responses significantly higher 
than the three species of Env which induced lowest proliferation, namely M. gordonae, 
M. kansaii and M. marinum (p < 0.05). In addition, M. chelonae was able to induce 
significantly higher proliferative response than M. marinum (p= 0.0073).   
 
Having identified that there were Env-responding T cells in the PBMCs of the healthy 
local population, based on proliferative responses, IFN-γ production following Env 



























Figure 1: Lymphoproliferative response of PBMCs in response to Env lysates. Each data 
point represents the average stimulation index (SI) of triplicate assays based on cells of a 
single subject. The short solid bars indicate the median SI of ten subjects in response to 
each antigen. Differences between antigen pairs were tested by the Mann-Whitney U test. 








4.3 Human IFN-γ response to Env 
The levels of IFN-γ secretion by lymphocytes in response to ten Env were assayed by 
ELISA from culture supernatants following 4 days of antigen stimulation.   
 
As described in the Methods, a positive result was identified as 4 standard deviations 
above the mean concentration in unstimulated (water alone) wells. The breakpoint (cut-
off value) was found to be 40 pg/ml. This is consistent with other published studies using 
similar methods (Wu-Hsieh et al., 2001). It can be seen that stimulation with all the Env 
lysates resulted in positive IFN-γ production in the majority of the ten donors, and this is 
consistent with the significant lymphoproliferative responses, again suggesting a high 
level Env-responding lymphocytes in the population. 
 
The level of IFN-γ production in response to M. avium was the highest, followed by PPD 
and M. scrofulaceum. The median IFN-γ levels were 1236.46 pg/ml, 926.43 pg/ml and 
726.67 pg/ml respectively. M. terrae, M. gordonae and M. marinum induced lowest 
levels of IFN-γ production. The rest of the Env tested (M.  smegmatis, M. szuglai, M. 
kansaii, M. fortuitum and M. chelonae) induced moderate levels of IFN-γ production. 
 
The range of individual IFN-γ responses to any given Env lysate spanned approximately 
2 logs, suggesting a high degree of heterogeneity in spite of common BCG vaccination 
experiences in the study population.  Although antigens present in PPD should be highly 
similar to BCG vaccine antigens, the range of responses to PPD itself spanned 1.5 logs, 
thus in some individuals the memory responses to BCG may have waned. This 
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heterogeneity of responses to each Env lysate led to few significant inter-antigen 
differences. The level of IFN-γ secretion in response to M. avium was significantly higher 
than to M.  smegmatis, M. szuglai, M. gordonae and M. marinum (p<0.05). By contrast, 
and somewhat surprisingly, IFN-γ production in response to PPD was only significantly 
higher than M. gordonae (p = 0.0257) which elicited the weakest IFN-γ responses. 
 
Correlation of IFN-γ production against the Env species was analysed (Table 4.1) to 
determine the extent to which each individual recognised more than one Env species. 
Cross-reactivity between lysates of Env was apparent, with the correlation coefficients 
ranging from 0.406 to 0.891. There were particularly high correlation coefficients 
between PPD and M. avium, M. fortuitum (r>0.8). High correlation coefficients between 
M. szulgai and M. avium, M. gordonae and M. fortuitum were also observed (r>0.8).  
However, for M. terrae and M. chelonae, the correlation coefficients were not significant 














































Figure 2: IFN-γ response of PBMCs to Env lysates. Each data point represents the mean 
of triplicate assays on PBMCs from a single subject. The short solid bars indicate the 
median IFN-γ response to each antigen.  The broken line shows the breakpoint for 
positivity (4 SD above the mean of unstimulated cells, i.e. 40 pg/ml). Differences 














Table 4.1 Correlation coefficients of IFN-γ responses to different Env species in the study 
cohort (n=10). All data were statistically significant (p<0.05) by Spearman rank 




4.4 Concordance between proliferative response and IFN-γ production against 
Env 
The relative response of the population to the Env lysates based on lymphoproliferation 
versus IFN-γ production is further examined in figure 3, where both results are shown in 
parallel for comparison.  This was to determine the extent of agreement between the two 
assays.  
 
Overall, the relative magnitude of proliferation responses and IFN-γ levels were in 
agreement for most of the Env, with exceptions of M. terrae (SI high, IFN-γ low) and 
PPD (SI low, IFN-γ high) which elicited discordant responses. PPD induced lower 
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proliferative responses than all ten Env lysates in 7 of 10 donors, although all donors 
were previously BCG vaccinated. M. avium elicited the highest proliferative and IFN-γ 
responses, whereas M. gordonae and M. marinum elicited the lowest responses on both 
assays.  
   
As fig 3 suggested that certain species may induce strong proliferative responses but not 
IFN-γ production and vice-versa, the extent to which these two parameters correlated was 
investigated (Fig. 4). As seen in figure 4A, by using the median antigen stimulation index 
(1.72) and IFN-γ response (360 pg/ml) to all Env to segregate high and lowe-responders, 
four different patterns of Env responses were detected in the study cohort, namely: SI 
high IFN-γ high, SI high IFN-γ low, SI low IFN-γ high and SI low IFN-γ low.  
 
To investigate which Env was the most predominant in each of these four responses 
patterns, donor responses to each Env were evaulated in table 4.2, and percentages of 
donors showing each of the four response patterns are shown in figure 4B. Figure 4B 
reveals that with three exceptions (sme, szu, ter), where there was discordance between SI 
and IFN-γ as measures of response to a particular Env lysate, the SI low IFN-γ high 
response was much more likely than the SI high IFN-γ low response. The discordant 
response was not due to outliers. 





























Figure 3: Relationship of IFN-γ production (upper panel) and proliferative responses 
(lower panel) in response to ten Env species and PPD. 10th, 25th , 50th , 75th and 95th 
percentiles are indicated. 
 
                         





The highest percentages of subjects showing the high SI high IFN-γ response pattern 
occurred in response to M. avium and M. terrae. In particular, the response to M. avium 
was the most homogenously high, since no subject had a SI low IFN-γ low response 
pattern for M. avium.  Thus M. avium antigens are strongly recognised in the study 
cohort. 80% of donors gave high IFN-γ responses to M. avium while the remaining 20% 
who had low IFN-γ  responses still showed strong lymphoproliferative responses to M. 
avium. Half of the donors showed a SI high IFN-γ high pattern in response to M. terrae, 
thus this species ranks highest for this response pattern among all the antigens tested. M. 
gordonae, M. kansaii and M. marinum were weakly antigenic in our study population. 
Majority of donors had a pattern of SI low IFN-γ low when their lymphocytes were 
stimulated with these three species of Env. M. marinum was most weakly antigenic in 
this group – no subject gave an SI high response, and only 3 of the ten donors had high 
IFN-γ  production. For the rest of the Env species (M. smegmatis, M. chelonae, M. 
szuglai and M. scrofulaceum) equal percentages of the four patterns were observed. It is 
interesting to note that the response pattern to PPD was approximately the same this latter 
group of Env, in spite of previous BCG vaccination.  Half of the subjects were SI low 
IFN high in response to PPD, thus PPD ranks highest in this response pattern amongst all 
antigens tested. Approximately 80% of donors had low lymphocyte proliferation against 









Figure 4A: Response patterns of donors as a group to specific Env, based on relative 
magnitude of IFN-γ and proliferative responses. Each symbol represents one of the 
antigens studied. Responses by each of the ten subjects to the same Env was given the 
same symbol. The horizontal line shows the median of antigen stimulation index (1.72) 
and the vertical line shows the median of IFN-γ concentration (360 pg/ml) to all the ten 
Env lysates. Based upon these two medians, the figure was divided into four quadrants, 
denoting the four patterns of antigen response: SI high IFN-γ high, SI high IFN-γ low, SI 











In summary, amongst Env tested, there was evidence for M. avium and M. terrae being 
the most consistently recognised species in the local population studied, whereas PPD 
appeared to yield relatively strong IFN-γ but weak proliferative responses. Given the 
BCG-vaccination history of all the donors, several hypotheses were considered. It was 
possible that BCG-induced memory responses had waned for some subjects, and BCG-
induced responses could not be boosted by further natural Env exposure. Alternatively, it 
was possible that proliferative responses had no bearing on actual functional protection, 
whereas IFN-γ responses might be better associated with protection.  Thus, the further 
experiments were undertaken to determine whether proliferative responses were linked to 
functional outcomes, and cytotoxicity against BCG-infected target cells was taken as a 





  SI high IFN-γ low SI high IFN-γ high SI low IFN-γ low SI low IFN-γ high 
avi 2 4 0 4 
for 3 2 1 4 
gor 0 2 7 1 
kan 0 1 6 3 
mar 0 0 7 3 
scr 2 2 3 3 
sme 3 4 3 0 
szu 4 2 3 1 
ter 3 5 2 0 
che  1 3 4 2 
PPD 0 2 3 5 




Table 4.2 Summary of numbers of subjects showing each of the 4 Env response patterns 
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Figure 4B: Percentage of donors in each response pattern to Env lysates. Based on Table 
4.2, the number of donors (n=10) who exhibited each of the four response patterns was 










Based upon the response patterns in figure 4, it was possible to identify, for each subject, 
the specific Env inducing high SI (Envhi: the species which induced largest magnitude of 
lymphocyte proliferation for that donor) and low SI (Envlo: the species which induced 
lowest magnitude of lymphocyte proliferation for that donor). Thus for subsequent 
experiments, the response to Envhi was studied, with Envlo as the control and comparator.  
 
 
4.5 Cyotoxic activity in response to Env 
An effective cytotoxic T cell (CTL) response is important in controlling tuberculosis 
which is an intracellular pathogen. It was hypothesised that certain Env may prime cross-
protective responses against pathogenic Mtb by activating an appropriate CTL response 
against Mtb-infected cells. In all subsequent experiments, M. bovis BCG, which shares 
>99% genome-level homology with M. tuberculosis, was used as the surrogate organism 
for Mtb, as the antigens are largely identical. Thus non-adherent cells from the PBMCs of 
9 donors were tested for lysis of autologous BCG-infected macrophages, following 
stimulation with either Envhi or Envlo. Env lysate diluent served as a negative control, 
PPD and SKSD served as positive and irrelevant antigen controls respectively.  
 
Based upon the relative cytotoxic activity following antigen stimulation, the subjects 
were grouped according to the extent to which the response to Envhi exceeded PPD and 
the irrelevant antigen control (Fig. 5). The aim was to identify subjects whose Env-
stimulated lymphocytes gave better cytotoxic responses against BCG-infected cells than 
PPD-stimulated lymphocytes.  
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Marked differences in antigen specificity and magnitude of cytotoxic activity against 
BCG-infected target cells after Env stimulation were found in the study cohort. In vitro 
antigen stimulation always resulted in a better cytotoxic activity when compared with 
spontaneous cytotoxicity (Env lysate diluent control stimulation). In all cases, as 
anticipated, the Envhi response was stronger than the Envlo response. This indicates a 
positive relationship between proliferation and cytotoxic activity, although the 
association was not always statistically significant. We thus focused on the Envhi 
response, in comparison to the other antigens.  
 
Fig. 5A shows donors whose PPD-stimulated lymphocytes showed higher levels of 
cytotoxicity than Envhi -stimulated cells, but the latter response was equivalent to that of 
SKSD-stimulated cells. This suggests that the CTL response after Env stimulation was 
non-specific. Fig. 5B also shows donors whose PPD-stimulated lymphocytes showed 
higher levels of cytotoxicity than Envhi -stimulated cells, but the response of Envhi -
stimulated cells was also higher than that of SKSD-stimulated cells. Thus the Env-
induced cytotoxic response was specific but weaker than the PPD response. Fig. 5C 
shows donors whose Envhi -stimulated cells showed higher levels of cytotoxicity than 
PPD, and the latter response was also higher than that of SKSD-stimulated cells. This 
was a significant group whose Env-stimulated cytotoxicity was specific and exceeded 
that of PPD. Fig. 5D shows donors who also had much higher Env responses relative to 
PPD responses, but because of the high SKSD (non-specific) response, it is difficult to 
evaluate the significance of the Env response.  
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Overall, there was clearly some heterogeneity within this healthy BCG-vaccinated cohort 
in cytotoxic responses (to BCG-infected target cells) that can be recalled through Env 
stimulation. Due to the high degree of antigenic similarity between BCG and Mtb, the 
BCG antigens presented by the target cells are assumed to be almost identical to Mtb. 
These results support the possibility that differential responses to Env can result in 
differential ability to lyse Mtb-infected cells, thus suggesting one reason why a Envhi 
response can be protective – in the case of group C donors, possibly more protective than 
a PPD response.  In the subsequent work described in this chapter, group C subjects were 
investigated to uncover the mechanisms underlying the strong Envhi response in this 
group.  
 
4.6 Relationship between proliferation, IFN-γ production and cytotoxicity 
It was hypothesised that a higher proliferation or IFN-γ response to a particular Env 
species or PPD could be associated with stronger cytotoxic activity. If this were true, then 
it may be possible to predict whether an unknown individual has better Env-specific or 
PPD-specific CTL activity by assaying prolfierative and/or IFN-γ responses. This could 
be useful for determining who may not respond well to BCG vaccination. Donors whose 
levels of cytotoxic activity in response to Envhi were higher than PPD were grouped 
together and their proliferation and IFN-γ response to Envhi and PPD were compared 
(Fig. 6A and B). Envhi induced higher proliferative responses (p=0.026) but not IFN-γ 
responses than PPD in subjects whose levels of cytotoxic activity were higher in response 
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Figure 5:  Evaluation of target cell lysis after stimulation with Env lysates. Cytotoxicity 
was measured by 12 hr LDH released from macrophages infected with BCG, at an 
effector: target ratio of 10:1. The fold increase in cell lysis in stimulated relative to the 
unstimulated lymphocytes for 9 donors (D1 – D9) is presented. The Env lysates used for 
stimulation were chosen based upon the species which induced the high (Envhi) and low 
(Envlo) lymphocyte proliferation for the individual donor, from figure 4 data. Four 
patterns of response were observed (A-D) and the donors falling within each response 
pattern are shown in separate figures. Means of triplicate wells are shown. Error bars 
indicate 2 SD from the mean. Based on the Student t test, * p < 0.05 and ** p < 0.005 in 
the comparison to the other antigen-stimulated lymphocytes. §, significantly more than 
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Figure 6: Evaluation of the proliferative response and IFN-γ response against Envhi, Envlo 
and PPD among nine subjects whose levels of CTL activity in response to Envhi  was 
higher than PPD (Donor 1, 3, 4, 7, 9; graph A and B) or lower than PPD (Donor 2, 5, 6, 
8; graph C and D). Each circle represents the average of triplicate stimulation index 
(graph A and C) or concentration of IFN-γ (graph B and D) of one healthy individual 
subject. The horizontal solid black lines indicate group medians. A and B: Comparison of 
SI and IFN-γ between Envhi and PPD. C and D: Comparison of SI and IFN-γ between 
Envhi and Envlo.  Significant differences between antigen pairs were determined by the 
Mann-Whitney U test. 





However, three out of four donors whose levels of cytotoxic activity in response to Envhi 
were lower than to PPD also had higher proliferative response to Envhi than to PPD. 
These results indicate that proliferation and IFN-γ production are not directly correlated 
with cytotoxic activity when comparing Env with PPD. 
 
Envhi generally induced higher levels of CTL activity than Envlo (observed in Fig. 5). As 
can be seen from figure 6C and 6D, Envhi induced higher proliferative responses than 
Envlo in donors whose levels of CTL activity in response to Envhi were either higher than 
PPD or lower than PPD (p=0.027). However, the differences were not significant in IFN-
γ response. These results suggest that cytotoxic activity may be associated with 
proliferation but not IFN-γ production, when comparing between different Env. 
 
4.7 Role of IFN-γ in Env-stimulated cytotoxic activity  
It is known that IFN-γ is important in the activation of CTL cells (Serbina et al., 2001), 
and in our study cohort, subjects responding to Env generally produced IFN-γ in response 
to Env stimulation (Fig. 2-4). However, the data from fig 6 suggested that the Env-
stimulated CTL response may not be associated with IFN-γ, thus this was specifically 
investigated next. IFN-γ produced in response to Env stimulation was neutralised by 
adding recombinant IFN-γ  receptor 1 (IFN-γ R1) at the point of antigen stimulation. 
Because it was desired to investigate the basis for response in those who responded 
strongly to Env, only subjects whose cells showed stronger cytotoxic responses after 
stimulation with Envhi than PPD were studied (D3, D4, D7, D9) (Fig. 7).  
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In agreement with Fig. 5, the median fold increase of cytotoxicity of Envhi -stimulated 
lymphocytes relative to non-stimulated cells (2.93) was significantly higher than PPD-
stimulated cells (1.877) (p=0.0038). The CTL activity in response to Env was not 
affected by blocking IFN-γ, whereas the median CTL activity in response to PPD 
dropped 3 fold (from 1.877 to 0.535) in the presence of IFN-γ inhibitor (p=0.030). This 
result was consistent in the four subjects studied. Therefore, following Env-stimulation, 
the cytotoxic response against BCG-infected target cells was IFN-γ independent, whereas 
cytotoxicity induced by PPD stimulation was at least partially dependent on IFN-γ. 
 
4.8 Role of different cell subsets in Env-stimulated cytotoxic activity  
The cell subsets (CD4+, CD8+ T cells, γδ T cells and NK cells) that could have cytotoxic 
activity in response to Env were then examined. As described previously, D3, 4, 7 and 9 
were studied because their cytotoxic response after stimulation Envhi was better than 
PPD. Levels of cytotoxic activity against BCG-infected target cells were assessed 
following depletion of CD4+, CD8+, γδ T cells or NK cells (Fig. 8). In the absence of 
either CD4+ or CD8+ T cells, cytotoxic activity in response to PPD was significantly 
reduced (totally abrogated in 3 out of 4 donors). In contrast, cytotoxic activity in response 
to Envhi  was signficantly reduced only in the absence of CD4+ T cells. Depletion of CD8+ 
cells caused minimal reduction in cytotoxicity, following Envhi stimulation. Depletion of 
γδ T cells and NK cells did not have signficant effect on killing of target cells by 
lymphocytes stimulated with either PPD or Envhi. These results suggest that Env-
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Figure 7: Blocking IFN-γ activity abrogated cytotoxicity of PPD-stimulated lymphocytes 
but not Envhi-stimulated lymphocytes.  Cytotoxicity exhibited by antigen-stimulated 
lymphocytes was measured by 12 hr LDH released from macrophages infected with 
BCG, at an effector: target ratio of 10:1, with and without added IFN-γ R1 which blocks 
IFN-γ activity. The fold increase in cell lysis in stimulated relative to the unstimulated 
lymphocytes is presented. In the main figure, individual donor results are presented as 
means of triplicate assays in one representative experiment of two, error bars indicate 2 
SD from the mean. Inset:  the group medians, 25th and 75th percentiles are presented, 
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Figure 8: Effect of cell subset depletion on cytotoxic activity in response to Envhi and 
PPD. Average fold increase of cytotoxicity relative to unstimulated cells of each subject 
(n=4) is presented with no cell depletion (+) or after specific cell subset depletion (-). 
Main figures: means of triplicate assays for each subject shown, error bars indicate two 
standard deviations from the mean. Inset: medians, 25th percentile and 75th percentile for 





4.9 Cell subsets expansion in response to Env  
Figure 8 results suggest that CD4+ T cells may be more important in Env-stimulated 
target cell lysis than CD8+T cells, γδ T cells and NK cells. We next considered whether 
this cytotoxic activity is related to the relative expansion of the individual cell subsets 
following Env stimulation. Hence, the differences in proportion of CD4+ T cells, CD8+ T 
cells, γδ T cells and NK cells from lymphocytes stimulated with Env and PPD, compared 
to unstimulated cells were investigated.  
 
Because of limitation of sample from the three donors (D4, 7, 9) described above, cell 
subsets expanded in response to Env was assayed using lymphocytes from two donors 
(D2, 6) whose CTL activity was stronger in response to PPD than to Envhi , and two 
donors (D1, 3) whose CTL activity were stronger in response to Envhi  than to PPD. Cells 
were stained with antibodies against CD4, CD8, γδ TCR and CD56 after 5 day 
stimulation with Envhi, Envlo or PPD (Fig. 9). The percentages of γδ TCR+ T cells and 
CD56+ cells increased in all four donors regardless of the type of antigen stimulation (γδ 
TCR+ cells doubled in most cases), but the difference from unstimulated was not 
statistically significant. Patterns of changes in the percentages of CD4+ and CD8+ T cells 
were similar among Envhi, Envlo and PPD stimulated lymphocytes.  
 
Percentage of CD4+ cells in two subjects decreased to a small extent after stimulation 
(with proportional increase in CD8+ population) after stimulation with Envhi, Envlo and 
PPD, but the change was not statistically significant as a group (D3, 6). Proportional 
increase in both CD4+ and CD8+ populations was found in two subjects -- D1, who 
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belongs to the group with stronger CTL in response to Envhi than PPD and D2, who 
belongs to the group with stronger CTL in response to PPD than Envhi. Only one donor 
(D3) showed a significant increase in CD8+ T cells, whose proliferation, IFN-γ 
production and cytotoxic response were higher against Envhi than PPD (Fig. 2-5).  This 
suggests that the Env response in these donors, whilst CD4+ cell-dependent (Fig. 7), is 




n=4 CD4+ CD8+ γδ TCR+ CD56+ 
Env hi 0.89±0.65 1.07±0.29 1.62±1.07 1.11±1.07
Env lo 0.92±0.33 1.07±0.33 2.05±1.35 1.14±0.26
PPD 0.93±0.65 1.14±0.32 2.71±4.75 1.09±0.12
 
Table 4.3: Mean fold change in cell proportions after Env stimulation, expressed as 
percentage of positive cells ± 2SD.  
 
 
4.10 Th1 or Th2 cells response to environmental mycobacteria 
Existing literature suggests that a high Th1/ Th2 ratio is helpful for the host to control the 
Mtb infection (Lienhardt et al., 2002).  We then investigated whether the cells that 
expanded when stimulated with Env were preferentially Th1 or Th2 cells. IL18R and 
ST2L are found consistently expressed on human Th1 and Th2 cells respectively (Chan 
et al., 2001), thus these markers were used to detect expansion of Th1 and Th2 cells after 
5 days of stimulation with Envhi, Envlo, PPD or Env lysates diluent (unstimulated control) 
(Fig. 10).  
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Figure 9: CD4+, CD8+, γδ TCR+ T cell and CD56+ cell expansion in response to Envhi, 
Envlo and PPD. Lymphocytes were stimulated with Envhi, Envlo, PPD or Env lysate 
diluent (unstimulated control) for 5 days and the percentage of cells expressing the 
respective surface markers was analysed by flow cytometry, gating on the lymphocytes.  
Each symbol represents the mean of duplicate assays performed on cells of one subject 
(n=4, for every parameter). No significant difference was found between stimulated and 
unstimulated cells with respect to each antigen (statistics by Mann-Whitney U test). 
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Percentages of IL18R+ or ST2L+ cells induced by Envhi, Envlo and PPD did not differ 
significantly when the donors were grouped, although the proportion of both types of 
cells generally increased over unstimulated cells for most donors.  
 
Donor 6 had an unusually high proportion of both IL18R+ and ST2L+ cells (3 - 4 fold 
higher than other donors), even in unstimulated cells (unstimulated vs stimulated: 
6.4%/11.75% IL18R+; 8.6%/ 12.4% ST2L+). This donor’s cells showed much increased 
proportions of IL18R+ and ST2L+ cells in response to PPD (compared to other donors), 
and decreased proportions in response to Envhi and Envlo. He had an overall high and 
non-specific CTL activity upon stimulation with all the antigens tested and the CTL 
activity was higher in response to PPD than Envhi. His proliferative response against 
Envhi was higher than PPD, but the Envhi specific IFN-γ production was five times lower 
than PPD, which was in agreement of the decreased percentage of IL18R+ cells in 
response to Envhi. This donor’s cells are thus activated without exogenous stimulation 
and this may have resulted in a non-specific CTL activity which may not be Env or PPD-
specific. 
 
For the rest of the donors, no significant polarisation of IL-18R+/ST2L+ cells occurred 
upon stimulation with either Envhi or Envlo. This suggests that Env do not specifically 
prime a Th1 response. By contrast, PPD induced 4 times and 2 times more IL-18R+ cells 
compared with PBS-treated cells, respectively for those with CTL activity PPD > Envhi 
(Donors 1 & 3), and those with CTL activity Envhi > PPD (Donors 2 & 6). There was no 
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similar change in proportions of ST2L+ cells. This suggests that overall, PPD induces 
responses polarising towards Th1 responses. 
 
4.11 Cytokines induced by Env 
 To investigate the cytokine profile induced by Env, IL-4, IL-10, IL-12 (p70) and TNF-α 
from supernatant of 48 hr Env-stimulated PBMCs were measured using the Bioplex 
cytokine reagent kit. A positive result was defined as 2 SD above the mean concentration 
in unstimulated wells. The concentrations of IL-12 (p70) in most stimulated wells were 
found below this break-point, probably because we missed the optimal time point of IL-
12 (p70) detection, which is an early secreted cytokine after in vitro stimulation. It was 
not possible to perform cytokine measurements at all the optimal time-points because of 
the limited donor sample/cells. 
 
Figure 11 shows IL-4, IL-10 and TNF-α responses against ten Env species. Most Env 
induced positive IL-4, IL-10 and TNF-α responses (only M. gordonae, M. kansasii and 
M. marinum were below the breakpoint).  The rank order of antigens with respect to 
cytokine production was similar for all the three cytokines. The species that induced 
moderate cytokine production were M. avium, M. fortuitum M. scrofulaceum, M. szuglai 
and PPD, whereas M. chelonae, M. terrae and M. smegmatis stimulated the highest levels 
of cytokine production.  
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Figure 10: Proportion of lymphocytes expressing IL-18 R or ST2L, in response to Envhi, 
Envlo and PPD. Lymphocytes from the four donors were stimulated with Envhi, Envlo, 
PPD or Env lysate diluent (unstimulated control) for 5 days and the percentage of IL18R+ 
and ST2L+ cells was analysed by flow cytometry.  Each pair of symbols represents the 
mean of duplicate assays performed on cells of one subject. No significant difference was 






About half of the species of Env tested induced a higher level of cytokine production than 
unstimulated cells for at least one of these three cytokines. However, only M. 
scrofulaceum stimulated significantly higher levels of all three cytokines than 
unstimulated cells. M. terrae, M. chelonae and PPD induced significantly higher IL-4 
secretion than unstimulated cells and M. smegmatis and M. terrae stimulated cells had 
higher IL-10 than unstimulated cells. For TNF-α, cells stimulated with M. avium, M. 
szuglai, M. chelonae and PPD gave stronger responses than unstimulated cells. M. 
chelonae induced higher levels of TNF-α than M. gordonae, M. kansasii and M. marinum 


















































Figure 11: Cytokine responses of PBMCs against Env lysates (n = 5, four of the donors 
belong to the group Envhi> PPD in figure 5). IL-4, IL-10 and TNF-α from supernatants of 
48 hr in vitro stimulated cells were measured using the Bioplex cytokine reagent kit. 
Mean of duplicate assays shown, error bars indicate 2 SD from the mean. Cytokine 
production 2 SD above the mean concentration in unstimulated wells (‘uns’) was 
considered a positive result. *p < 0.05, for differences between antigen pairs determined 
using the Student t test. §, significantly more than unstimulated cells. 
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4.12 Discussion  
This study has demonstrated that even in an apparently uniform cohort of Singaporeans 
with similar age and BCG vaccination experiences, there is a significant diversity in 
responses to Env, and this exerts a profound influence on the ability to kill BCG-infected 
cells. There are many implications to these observations. They will be discussed here in 
the context of reasons for the diversity, the cell types and cytokines involved in the Env-
mediated cytotoxic response and how our results may contribute to understanding 
immune correlates of TB protection and future TB vaccine development. 
4.12.1 Diversity of Env responses 
There was relatively good concordance between proliferative responses and IFN-γ 
production in response to Env in the study cohort (Fig 3 and 4), in agreement with the 
study in Malawi (Weir et al., 2003). Immune responses to M. avium were clearly the 
strongest by both assays, statistically equivalent to PPD responses in spite of the prior 
BCG vaccination histories of all subjects. Indeed, based on the Mycobacterium 
phylogenetic tree (see Fig. 2.1), M. marinum is the closest relation to M. tuberculosis 
complex amongst the species studied, yet it elicited the weakest response in our 
population. Studies on Mtb have shown that a few immunodominant proteins account for 
most of the T cell responses in TB patients (Tully et al., 2005). Thus, it is likely that in 
BCG-vaccinated subjects, the strength of the T cell response to any given Env species 
may depend more on whether those immunodominant proteins are significantly shared 
between that species and BCG, than the total actual number of gene homologues. It has 
been shown through comparative genome analysis that there are 219 orthologous 
(conserved) genes of Mtb and M. leprae of which M. marinum lacked only nine, whereas 
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M. avium lacked 20 including the genes of the RD1 region, which are also absent from 
M. bovis BCG (Marmiesse et al., 2004). However, several of the highly immunogenic 
proteins of the Mtb complex are secreted proteins (some are encoded within RD1, e.g. 
ESAT-6), and are found in the early culture filtrate. The response to a bacterial lysate 
which contains little of the culture filtrate proteins would be skewed towards other shared 
somatic antigens, which may be of relatively lower immunogenicity.  This could explain 
the discrepancy between phylogenic distance and the observed responses to specific Env 
species, in view of prior BCG vaccination.  
 
A simpler explanation could be that the memory response to BCG has waned over time – 
it is known that positive PPD skin test responses post-BCG vaccination fades over 10 -15 
years (Menzies et al., 1992). Thus, if BCG-attributable responses are not considered, the 
strength of responses to each Env may simply reflect the frequency of contact with such 
Env in our environment. This would explain the predominance of fast-growers amongst 
the Env inducing the strongest proliferative responses. Support for this explanation is also 
found in a recent study showing that the immune response following M. bovis challenge 
in cattle previously inoculated with M. avium was biased towards antigens present in M. 
avium, whereas the response following M. bovis alone was biased towards antigens 
present in M. bovis, indicating an imprinting of memory to avian antigens on T 
lymphocytes (Hope et al., 2005).   
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4.12.2 CTL in response to Env  
There is some evidence that lysis of infected Mtb- infected macrophages is a prerequisite 
for killing of intracellular mycobacteria (Silva et al., 2001), although others have also 
suggested that there may not be a direct correlation of lysis with mycobacterial death 
(Stenger et al., 1997). We measured the ability of Env-responding cells to lyse BCG-
infected target cells as an indicator of the potential lytic response against Mtb-infected 
cells, since there is significant similarity in the antigens produced by the two organisms, 
given that the genomes are >99% homologous. We also considered this an in vitro model 
of how Env-sensitised T cells may respond to BCG-infected cells immediately post-BCG 
vaccination. 
 
We found that Envhi-stimulated cells could kill the BCG-infected target cells and the level 
of cytotoxic activity was signficantly higher than PPD-stimulated cells in half of the 
subjects (Fig. 5, C and D). This is surprising as we expected that PPD-responding T cells 
would be more likely to be specific for peptides presented by BCG-infected macrophages, 
than Env-responding T cells, given that PPD is derived from Mtb. Yet Envhi-stimulated 
cells had higher cytotoxicity by direct and/or cross-recognition of the peptides being 
presented on the BCG-infected cells. This is probably because in the selected subjects, 
there were actually more responder T cells specific for Envhi antigens than PPD, most 
likely through persistent exposure to Env. Our observations suggest one mechanism 
which could explain why BCG may not be effective in Env-sensitised humans – the BCG 
vaccine may not have a chance to proliferate in the face of lysis of BCG-infected cells. 
On the positive side, subjects whose Env-responding cells have strong cytotoxic activity 
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are likely to have good lytic ability against Mtb-infected cells, and this could relate to 
better host immunity to Mtb infection. 
 
4.12.3 Cell types involved in Env response 
We noted that the Env cytotoxicity response was CD4+-dependent but CD8+-independent 
(figure 8), and considered whether our experimental results could be biased due to 
introduction of Env antigens exogenously in the assay. However, the PPD cytotoxicity 
response was noted to be dependent on both CD4+ and CD8+ cells, so apart from being 
presented via MHC II to CD4+ T cells, the soluble PPD antigens evidently also have 
access to CD8+ T cells in our experimental system, most likely through cross-
presentation. Highly degraded antigens in PPD could bind to cell surface MHC I (Smith 
et al., 1999). Studies on Mtb HSP70 have shown that chaperoned exogenous antigens that 
are degraded within the macrophage phagocytic vacuole will directly bind to post-Golgi 
MHC I molecules (Tobian et al., 2004). It is also possible that exogenous antigens in the 
APC get cross-presented by other APC which take up the primary APC after apoptosis 
(Schaible et al., 2003).  
 
We considered reasons why the CD8+ cells appeared to have a less significant cytotoxic 
role in the Env response than the PPD response. It is known that CD4+ T cells are 
required for the development of cytotoxic CD8+ T cells during Mtb infection in murine 
model (Serbina et al., 2001). Thus, it is possible that the CD4+ T cells in response to Envhi 
do not help to develop functional cytotoxic CD8+ T cells whereas PPD-specific CD4+ T 
cells in response to PPD do. It could be because CD4+ T cells in response to Env did not 
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stimulate significant IL-15, which is the cytokine critical for the development of CD8+ 
cytotoxic effector cells (Serbina et al., 2001, Tan et al., 2002), or CD4+ T cells response 
to Env did not stimulate significant IL-2 secretion, which are also found to help CD8+ T 
cells (Boom et al., 2003). 
 
Others have shown that the CD4+ T cells are more likely to use the perforin-dependent 
mechanism for cell-killing than the Fas-dependent mechanism (Yasukawa et al., 2000) 
and highly differentiated CD4+ T cells acquire lytic ability (Lucas et al., 2004). However, 
Env stimulation did not significantly change the proportion of CD4+ over CD8+ T cells 
although the CD4+ cells were the major population responsible for killing the BCG-
infected target cells. This could be because the effector memory CD4+ T cells 
differentiated and acquired lytic ability at an early stage of stimulation and many 
differentiated cells died soon after few days of stimulation (Zinkernagel et al., 1993). 
Thus, the remaining population of functional CD4+ T cells may have cytotoxic activity 
without notable increase in percentage of CD4+ T cells. CD4+ T cells are known to have a 
key role through all stages of Mtb infection and the relative importance of cytokine 
secretion and cytolytic function in different stages is also varied (Boom et al., 2003). The 
ability of Env-responding CD4+ T cells to secrete cytokines and perform the cytolytic 
function detected in our study may be an important mechanism that confers protection 
against Mtb infection. 
 
The proportional increase of NK cells and γδ TCR+ cells upon stimulation with Env was 
higher than CD4+ or CD8+ T cells (Fig. 9). Τhis is interesting because there is evidence 
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that γδ TCR+ cells and NK cells have the potential role in killing of infected cells in Mtb 
infection (Behr-Perst et al., 1999; Esin et al., 2004). However, depletion of CD56+ or γδ-
TCR+ cells did not significantly influence cytotoxic activity of Env-responding cells (Fig. 
8), so we could not conclude that they played a significant role in this regard. 
 
4.12.4 Cytokines and CTL in response to Env  
It is known that exogenous IFN-γ can augment the development of CTL activity in mixed 
lymphocyte cultures, and neutralising antibodies to IFN-γ can inhibit the development of 
CTL activity in antigen- stimulated lymphocyte cultures (Siegel et al., 1988). In addition, 
IFN-γ and TNF-α are important in the early stages of induction of both murine CD4+ and 
CD8+ cytotoxic T cells by M. leprae heat shock protein (hsp) 65 kD (Sasiain et al., 1998). 
However, our study showed that cytotoxic activity of Env-responding cells was 
independent of IFN-γ (Fig. 7). Studies of dengue virus infection suggest that IL-7 and IL-
2 play important roles in growth and induction of human antigen-specific CD4+ cytotoxic 
T cells in vitro (Berrios et al. 1996). It is possible that Env-stimulated cells may produce 
sufficient IL-7 and IL-2 which may act as alternative stimuli for generating and 
maintaining the cytotoxic T cells.  
It is not likely that our observations were due to inadequacy of inhibition of IFN-γ in the 
experimental system because cytotoxic activity of PPD-stimulated cells was effectively 
blocked in the same system (Fig. 7). It is known that in human mixed-lymphocyte 
cultures, IFN-γ mainly helps to expand CD8+ cytotoxic T cells (Billiau, 1996). We 
observed that cytotoxic activity of PPD-stimulated cells was dependent of CD8+ 
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cytotoxic T cells (Fig. 7), thus this could be the component of the PPD-stimulated CTL 
which is susceptible to IFN-γ inhibition .   
Synthesis of IL-10 is uniquely dependent on endogenous proinflammatory cytokines 
TNF-α and IL-1β, when trigged through both Toll-like receptor 2 (TLR2) and TLR4 via 
adaptor molecule CD14 (Akira et al., 2001). Lysates of fast-growing mycobacteria such 
as M. chelonae stimulated a higher level of IL-10 and TNF-α  production than antigens 
from slow-growers M. avium or PPD which stimulated the highest IFN-γ responses (Fig. 
11 and Fig. 2). It is known that the mycobacterial ligands for TLR2 include 
lipoarabinomannan (LAM), which is abundant in mycobacterial cell walls. A high 
proportion of uncapped LAM at arabinan domain (AraLAM) or LAM capped with 
phosphoinositide motifs (PILAM) is correlated with higher potency of induction of IL-10 
and TNF-α (Khoo et al., 1995). The cell wall of fast-growing M. chelonae has a higher 
proportion of these two kinds of LAM than slow-growers such as Mtb (Khoo et al., 
1995) and this could explain their higher levels of induction of IL-10 and TNF-
α production (Fig. 11), and the converse response to the slow-growers and PPD. Our data 
are also in agreement with the results from Malawi studies by Weir et al. (Weir et al. 
2004). The induction of IL-10 by the fast-growers is of interest because of prior evidence 
that another fast-grower M. vaccae can induce regulatory T cells which modulate the 
inflammatory response in a murine model of asthma (Zuany-Amorim et al., 2002). 
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4.12.5 Conclusion 
Mtb-specific cytotoxic activity is a significant mechanism for immune protection against 
TB, as evidenced by TB vaccine and challenge studies focusing on CTL generation 
(Santosuosso et al., 2005). The present work has shown the diversity of normal healthy 
human responses to Env and how Env-mediated cytotoxicity can kill BCG-infected target 
cells. Extrapolating this to Mtb-infected cells, which would bear highly similar antigens, 
each person’s immune experience to Env may be considered a factor influencing 
susceptibility to Mtb. Thus, the Env response could be an immune correlate of protection. 
This is a prospect which has not been significantly addressed in the understanding of 
human TB pathogenesis, and needs to be tested in larger scale human epidemiological 
studies. 
Even more significant is the effect of Env-sensitisation on BCG. It has long been 
suspected that Env-sensitisation reduces efficacy of BCG vaccination in humans, but this 
work is the first to provide an immunological mechanism by which this could happen. 
There are several implications. First, it is possible that for those whose cytotoxic activity 
of Env-stimulated cells is better than PPD-stimulated cells, subsequent BCG vaccination 
may not be effective. This could be one means of predicting BCG efficacy in a 
population. Second, in the quest for a new TB vaccine, consideration should be given to 
whether Env-sensitised adults, who constitute the majority of those in developed 
countries who need the vaccine, will benefit. Otherwise, any new vaccine may suffer 
from the same problems which are currently plaguing BCG. Third, the protective 
mechanism conferred by natural Env sensitisation may potentially be harnessed in 
 79
vaccination or immunotherapy against TB. Indeed, a fast growing Env, M. vaccae, has 
already undergone clinical trials as an adjunctive immunotherapeutic agent against TB 
and it has shown to be successful in reducing time to sputum conversion (Johnson et al., 
2000). The finding of dependence on CD4+ T cells in Env-attributable cytotoxic activity 
(Fig. 8) and the correlation of cytotoxic activity with protection (Bonato et al., 1998) 
would help to design vaccines for the best balance of responses, and clinical tests to 
monitor or predict vaccine efficacy in Mtb infection. 
 
A limitation of these studies on human subjects is that it focuses on the investigation of 
the cytotoxic effector cells in vitro, which may not be truly reflective of the in vivo 
situation. In some cases, a dominant cytolytic pathway that is essential in vitro may not 
be essential  in vivo (Barchet et al., 2000). Moreover, it is not possible to quantify the 
dose, remoteness or identity of Env species to which each individual has been exposed. 
Hence, in a later chapter of this thesis, cytotoxic responses in Env-sensitised mice are 







CHAPTER 5  IMMUNE EFFECTS OF MURINE IMMUNISATION WITH 
ENVIRONMENTAL MYCOBACTERIA 
5.1 Introduction 
Members of the Mycobacterium genus share significant degree of genetic homology, and 
thus have many antigens in common. It has been postulated that these similarities may be 
one major reason for cross-protective responses conferred by prior exposure to Env upon 
subsequent challenge with M. tuberculosis (Takashima et al., 1988). In the previous 
chapter, the data on the human response to Env revealed diverse responses to 
environmental mycobacteria (Env) which results in differential cytotoxic activity to 
BCG-infected target cells. However, because of the uncertainty of species of Env to 
which each individual had been previously exposed, the influence of the cross-reactivity 
of Env on the subsequence anti-tuberculosis responses remains unanswered. The aims of 
the work presented in this chapter are to characterise the nature and the extent of cross-
reactivity of Env and to study the T cell subsets involved by studying responses of mice 
immunised with selected species of Env. 
 
 In this chapter, murine studies performed to determine the effects of immunisation with 
Env are described. Following murine immunisation with selected species of Env, the 
following were studied:  
a. Patterns of proliferative response against lysates from ten environmental 
mycobacterium species, to determine extent of cross-reactivity.  
b. Relative expansion of CD4+ and CD8+ T cells in response to different Env 
c. Homologous and heterologous mycobacterium-specific cytotoxic responses induced  
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d. Cell types responsible for cytotoxic activity, demonstrated through cell depletion 
assays.   
 
5.2 Cross-reactivity between species demonstrated through proliferative 
responses  
To investigate the extent of cross-reactivity between different Env species in the Balb/c 
host following specific Env exposure, this experiment examined cellular responses to 
lysates of ten Env species, in mice with prior exposure to other Env lysates. Balb/c mice 
were i.p. immunised four times with heat-killed M. chelonae, M. smegmatis or M. bovis 
BCG over four weeks, and their splenocytes harvested for testing in vitro proliferative 
responses to ten Env lysates. The species used were as same as those in chapter 4.  
 
As expected, the proliferative response was generally higher when the antigen used for in 
vitro stimulation was the same as that with which the mice had been immunised (Fig 12). 
M. avium, M.  smegmatis, M. szuglai, and M. scrofulaceum lysates generally yielded the 
highest proliferative responses in all three types of mice.  
 
For cells of M. chelonae-immunised mice, the response to most Env species (except M. 
terrae and M. fortuitum) was significantly higher than both control mice and M.  
smegmatis-immunised mice. Responses were even higher than BCG-immunised mice 
against lysates of M. kansasii, M. marinum and M. terrae. Overall, comparing the three 
types of immunised mice, cells of M. chelonae-immunised mice showed cross-reactive 
lymphocyte responses to the largest number of other Env species (Table 5.1).  
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For BCG- immunised mice, the proliferative response against PPD, M. avium, M. 
scrofulaceum, M.  smegmatis, M. szuglai, and M. kansaii was significantly higher than 
control mice. Of these antigens, only the response against M.  smegmatis, M. szuglai  and 
M. kansaii was higher than M.  smegmatis-immunised mice. In contrast, when compared 
to M. chelonae-immunised mice, BCG-immunised mice only responded significantly 
better to PPD.  
For M.  smegmatis-immunised mice, only responses to M. avium and M.  smegmatis were 
significantly stronger than control mice. This suggests that of the three types of 
immunisation performed, M. smegmatis immunisation confered least cross-reactivity to 








M. aviumM. smegmatisM. avium2
M. smegmatisPPDM. smegmatis1
M.  smegmat i s-
i mmuni sedBCG- i mmuni sed
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i mmuni sedAg
mice
     
Table 5.1: Significant proliferative responses to Env antigens following immunisation. 
Antigens are ranked (from highest to lowest) based upon magnitude of proliferative 
response (SI) in splenocytes of M. chelonae-, M. smegmatis- and BCG-immunised mice, 
against the antigen. Only responses significantly higher than control (PBS-immunised) 
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Fig. 12: Proliferation of splenocytes from M. smegmatis-, M. chelonae- and BCG- 
immunised mice in response to ten Env species and PPD. Proliferative responses were 
expressed as fold increase in SI relative to control (PBS-injected) mice, which is derived 
by dividing SI from immunised mice by mean SI from control mice. Means of triplicate 
wells are shown. Error bars indicate 2 SD from the mean. Based on the Student t test, the 
cellular responses to various antigens were considered significantly different when *p < 
0.05 or ** p < 0.005. The symbol § represents data significantly different (p < 0.05) 
when compared with SI of control mice. Data represent one out of three independent 
experiments with similar results. 
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5.3 Cell subsets expanded in response to environmental mycobacterium in mice   
It is known that both CD4+ T cells and CD8+ T cells can have cytotoxic activity in murine 
models of Mtb infection (Silva et al., 2000). Thus, the proportion of CD4+ T cells and 
CD8+ T cells in spleens of Env-immunised mice was next assessed by flow cytometry, 
directly after sacrificing the mice (Fig. 13).  
 
The proportion of CD4+ T cells in BCG-immunised mice was the highest, followed by M. 
smegmatis- and M. avium-immunised mice (Fig.13A). The CD4+ T cells in BCG- 
immunised mice made up half of the non-B cell splenocytes. The percentage of CD4+ T 
cells in M. smegmatis immunised mice was significantly less than those of BCG-
immunised mice but significantly more than those of M. avium-immunised mice (p < 
0.05). However, the proportion of CD4+ T cells in M. avium- and M. chelonae-
immunised mice was comparable to control mice, suggesting that these two Env species 
did not result in significant CD4+ cell expansion.  
 
It can been seen from figure 13B that the proportion of CD8+ T cell population in M. 
avium-immunised mice was the highest, constituting up to 28% of splenocytes. The CD8+ 
T cell population in M. smegmatis-immunised mice was smaller than in M. avium-
immunised mice but higher than in BCG-immunised mice (p < 0.05). Overall, there was 
a relatively minor expansion of CD8+ cells, relative to CD4+ cells following Env 
immunisation. The proportion of CD8+ T cells in M. chelonae-immunised mice showed 
no significant difference from those of control mice. Of all the Mycobacterium species 
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Figure 13: Immunisation with different Env species induced diverse frequencies of CD4+ 
and CD8+ T cells. Mice were immunised with 1x106 heat killed BCG, M. smegmatis, M. 
avium, M. chelonae or PBS thrice over 4 weeks. Splenocytes were subjected to flow 
cytometric analysis, gated on lymphocytes, on the day of harvest. Means of triplicate 
assays are shown. Error bars indicate 2 SD from the mean. Based on the Student t test, * 
indicates significant differences (p < 0.05) from all other immunisation groups. Data 
represent one out of two independent experiments. 
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which did not result in significant expansion of either CD4+ or CD8+ cells, relative to 
control mice without immunisation.   
5.4  Cytotoxic activity in response to environmental mycobacterium in 
environmental mycobacterium immunised mice 
It was established in figure 12 that there is considerable cross-reactivity in T cell 
recognition of other Env species in the Env-immunised mice. However, it is not clear if 
this cross-reactivity has functional consequences which may affect immune protection. 
Thus, the cytotoxicity of Env-reactive cells against BCG-infected autologous 
macrophages was next tested to determine if cross-protection is conferred, after 
homologous and heterologous in vitro antigen stimulation. 
 
Cytotoxicity against BCG-infected autologous target cells was measured in splenocytes 
from M. avium-, BCG-, M. smegmatis- and M. chelonae- immunised mice. As expected, 
comparing homologous versus heterologous responses in mice with any given Env-
immunisation, it was noted that homologous responses generally gave significantly 
higher cytotoxicity (Fig. 14). This can be seen from two sets of comparisons.  
 
First, for any given species of Mycobacterium-immunised mice, generally the highest 
level of cytotoxic activity was achieved when re-stimulated with the homologous antigen 
(Fig. 14A). For example, the level of cytotoxic activity of T cells from M. avium-
immunised mice was highest when in vitro restimulated with heat-killed M. avium, 
relative to other Env species, but comparable to BCG restimulation. Second, upon 
comparison of mice immunised with different environmental mycobacteria (Fig. 14A), 
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the highest level of cytotoxic activity of T cells upon in vitro restimulation with a given 
Env antigen was achieved by splenocytes from mice that were immunised with the same 
species. For example, when M. chelonae was used to restimulate T cells from 
differentially immunised mice, the highest level of cytotoxic activity was found in M. 
chelonae-immunised mice (p < 0.005). This was also true for BCG. Notably, for M. 
smegmatis-immunised mice, using M. chelonae as the restimulating antigen yielded 
comparable level of cytotoxicity as homologous antigen restimulation. This suggests that 
in mice previously sensitised with M. smegmatis, further boosting with M. chelonae 
antigens confers cross-protective cytotoxicity.   
 
The level of cross-protective responses was higher upon immunisation with fast growers 
than slow growers (Fig. 14B). M. chelonae-immunised mice showed the highest 
heterologous responses, followed closely by M. smegmatis. Cytotoxicity of cells from M. 
chelonae-immunised mice restimulated with heterologous antigens (M. avium, M. 
smegmatis) was significantly better than other mice given the same heterologous 
restimulation. Heterologous responses of M. avium- and BCG-immunised mice were 
much poorer – BCG-immunised mice notably produced weak cytotoxicity responses 
when restimulated with virtually all other antigens, despite mounting the strongest 
homologous response. Additionally, M. chelonae-immunised mice also mounted the 
strongest cytotoxicity response of all the mice, in the absence of in vitro restimulation.  
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Fig. 14: Immunisation with Env increased cytotoxicity against autologous BCG-infected 
target cells. Mice were thrice immunised with heat-killed M. chelonae, M. smegmatis, M. 
avium or BCG over 4 weeks before sacrifice. Splenocytes were stimulated for 5 days 
with heat-killed Env antigens derived either from the same or different species. 
Cytotoxicity was measured by 12 hr LDH released from macrophages infected with BCG 
(MOI 10:1) in the presence of in vitro restimulated lymphocytes. Means of triplicate 
wells are shown. Error bars indicate 2 SD from the mean. * p < 0.05 and ** p < 0.005, 
based on the Student t test.  §, significantly more than non-stimulated cells from the same 
mice. Fig. 14A and B are identical but display different statistical comparisons. A: Shows 
homologous vs heterologous antigen stimulation in the same mice, and homologous 
antigen response versus heterologous responses to the same antigen in other immunised 
mice. B: Shows heterologous responses in mice given different immunisations (cross-
















5.5 Role of different cell subsets in Env-stimulated cytotoxicity  
Given the evidence that cells from M. chelonae-immunised mice had significant 
cytotoxicity against BCG-infected target cells, the cell subsets which could be involved 
in this cytotoxic activity in M. chelonae-immunised mice were next examined.  The 
cytotoxicity assay was performed in the absence of CD4+ T cells, CD8+ T cells or CD56+ 
cells after stimulating the splenocytes with heat-killed M. chelonae. 
 
As shown in figure 15, CD4+ T cell depleted lymphocytes yielded 4.46% cytotoxicity, 
which is the same as those lymphocytes without stimulation (4.48%). There was a 
significant reduction of target cell killing of CD4+ T cell depleted lymphocytes 
(p=0.0033) compared to positive control cells without depletion (39.21%).  Thus, CD4+ T 
cells had an important role in the cytotoxic activity of cells from the M. chelonae-
immunised mice. The level of target cell lysis of CD8+ T cells and CD56+ cells depleted 
lymphocytes were 52.66% and 56.07% respectively, statistically comparable to positive 
control cells (no depletion). In fact, there was a slightly higher magnitude (10%) of 
cytotoxicity in the CD8+ and CD56+ cell-depleted wells. This could be because the CD8+ 
and CD56+ cell-depleted lymphocytes now had a higher concentration of CD4+ T cells. 
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Figure 15:  The effect of cell subset depletion on cytotoxic activity. Depletion of CD4+ T 
cells but not CD8+ T cells or CD56+ cells abrogated the cytotoxicity of M. chelonae-
stimulated lymphocytes in M. chelonae-immunised mice. The different cell subsets were 
depleted after antigen stimulation of lymphocytes but before effector-target cell co-
culture for the cytotoxicity assay.  Percentage of target cells lysed in the presence of un-
stimulated lymphocytes (‘uns’), stimulation with heat-killed M. chelonae (‘no depletion’, 
positive control), or stimulated lymphocytes without each of the cell subsets (CD4-, CD8-
, CD56-) are presented. Means of triplicate wells are shown. Error bars indicate 2 SD 
from the mean. Based on the Student t test, the differences in cytotoxic activity were 
considered statistically significant when p < 0.05. Data represent one out of two 
independent experiments with similar results. 
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5.6 Discussion  
Several disadvantages with human studies exist, including inter-human differences in 
remoteness of BCG vaccination and the inability to determine with certainty to which 
Env species each individual had previously been exposed. By immunising mice with 
specific Env species, it was possible to distinguish the effects of different Env species 
and the extent of cross-reactivity between species.   
 
5.6.1 T cells in response to Env in mice 
Splenocytes from M. chelonae-immunised mice were able to proliferate in response to 8 
out of 10 strains of Env and this proliferation was more than the proliferation of 
splenocytes from M. smegmatis-immunised mice (Fig. 12). In addition, for M. chelonae-
immunised mice, the levels of proliferation against 9 strains of Env were always higher 
than BCG- and M. smegmatis-immunised mice. This suggests that in M. chelonae-
immunised mice, there are more cross-reactive T cells which recognise shared antigens in 
the other Env lysates. Alternatively, there could be factors within the M. chelonae lysate 
which activated T cells more strongly than the other Env lysates. 
 
The proportion of CD4+ T cells and CD8+ T cells in splenocytes of M. chelonae- 
immunised mice was not significantly higher than naïve mice (Fig. 13). However, it was 
subsequently found (data in the next chapter) that in both CD4+ T cells and CD8+ T cells 
from M. chelonae-immunised mice, there was a higher proportion of cells of the 
activated/ memory phenotype (CD44+ CD45RBlow), compared with other types of mice 
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(Fig. 16). Thus, whilst the absolute proportion of T cell subsets from M. chelonae-
immunised mice was similar to those of naïve mice, these cells could be relatively more 
activated in the M. chelonae-immunised mice, thereby conferring better killing of 
infected target cells (Fig. 14).  
 
5.6.2 Heterologous activation of cytotoxicity against BCG-infected cells 
Some extent of cross-reactive cytotoxic T cell activation was observed between the three 
types of Env studied (Fig. 14). Cross protection can be partially explained by the 
phylogenetic tree of Mycobacterium species (Fig. 2.1). For example, the distance 
between M. chelonae and M. smegmatis in phylogenetic tree is close, whereas fast-
growers M. chelonae and M. smegmatis are much further from slow-grower M. avium on 
the phylogenetic tree. This could have a role in the extent to which shared antigens exist 
between species. This was evidenced by poorer target cell killing by T cells from M. 
avium- immunised mice when they were stimulated with heat killed M. chelonae and M. 
smegmatis, when compared with re-stimulation with M. avium (Fig. 14).           
        
Immunisation with M. avium or BCG did not lead to cross-protective cytotoxic responses 
upon boosting with other Env, especially the fast-growers. In particular, BCG-immunised 
mice produced weak cytotoxicity responses when restimulated with most other Env 
antigens, despite mounting the strongest homologous response. This is an important 
observation because it could explain why effector cells from BCG vaccination decrease 
over time, since subsequent Env exposure could not boost the recall response. 
Conversely, in our experimental conditions, memory responses to immunisation with M. 
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chelonae could be recalled with M. avium and M. smegmatis. Thus, it is likely that M. 
chelonae immunisation could be more successful than BCG immunisation, in terms of 
maintenance of memory responses through further natural Env exposure. These cross-
protective responses were intriguing given the phylogenetic distance between M. 
chelonae and M. avium (restimulating antigen), as well as between M. chelonae and BCG 
(infecting organism in target cells), and the reasons are not clear. Perhaps it is the nature 
of some immunodominant M. chelonae antigens and qualitative aspects of the antigen-
presentation and T cell activation process (e.g. via molecular chaperones) that generates 
memory cells which are more readily reactivated upon antigen restimulation.  
 
5.6.3 Activated CD8+ T cells did not perform CTL function 
 Depletion of CD8+ T cells did not abrogate the CTL function in M. chelonae-immunised 
mice (Fig. 15) whereas depletion of CD4+ T cells did. This is reminiscent of the data from 
our human study described in the previous chapter. Murine models of M. avium infection 
show that while depletion of CD4+ T cells exacerbate the infection, depletion of CD8+ T 
cells do not (Orme et al., 1992; Saunders et al., 1995). Nevertheless, in M. avium-infected 
mice, there is proliferation of IFN-γ producing CD8+ T cells (Gilbertson et al., 1999). It 
could be that Env tend to stimulate functional CD4+ T cells whereas the CD8+ T cells are 
stimulated via a bystander activation mechanism (Gilbertson et al., 2004) and do not 
contribute to the immune protection. Very recent data by Lazarevic et al shows that early 
in murine TB infection, the CD8+ T cells are predominantly cytotoxic but during chronic 
infection these cells switch to cytokine (mainly IFN-γ) production and exhibit minimal 
cytotoxicity. They find that this lack of CTL activity is not due to CD8+ T cell 
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exhaustion, and suggest that it is due to high antigen dose dictating the functional 
programme of CD8+ T cells during persistent TB infection (Lazarevic et al., 2005).  
 
5.6.4     Conclusion 
Human memory responses to BCG-vaccination wane over time (Menzies et al., 1992). 
The present work suggests one possible immunological mechanism of how this happens, 
as it was observed that cytotoxic activity of effector cells from BCG vaccination failed to 
be recalled by subsequent Env exposure (Fig. 14). In contrast, M. chelonae-specific 
memory responses could be boosted by several other species of mycobacteria, and most 
importantly, there was a significant functional outcome in the form of killing of BCG-
infected target cells. If BCG is seen as a surrogate for M. tuberculosis, then the lysis of 
infected cells is a potential mechanism for protective responses against the pathogen 
conferred by Env. Unfortunately, the results also verify what was suspected from our 
human study – that Env sensitisation affects the viability of subsequent BCG infection 
through this mechanism, and effective replication of the live BCG vaccine is central to 
generating good memory responses to the vaccination. These are clearly two mechanisms 
why BCG fails in certain geographical areas. For people living in these areas where the 
efficacy of BCG vaccination is low and who are highly exposed to Env, it is possible that 
vaccination with antigens from M. chelonae could result in longer lasting memory 
responses (than BCG vaccination) because of continuous natural Env exposure. 
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CHAPTER 6: IMMUNOMODULATORY EFFECTS OF ENVIRONMENTAL 
MYCOBACTERIA ON IN VIVO BCG CHALLENGE 
6.1 Introduction 
It is evident from the study by Zuany-Amorim et al  (Zuany-Amorim et al., 2002) that M. 
vaccae, a species of non-pathogenic environmental mycobacteria, has immune regulatory 
effects on allergic responses in the host. The aims of the work described in this chapter 
are to characterise the memory T cells induced by Env, and investigate whether Env 
induce functional responses which influence the course of infection caused by in vivo 
BCG challenge.  We hypothesised that Env immunisation could reduce inflammatory 
responses due to BCG challenge and yet limit the bacterial load by priming appropriate 
memory responses.   
 
Based on the same murine model of Env immunisation described previously, we 
investigated: 
   a. Proportions of of CD45RBlow T cells in the CD4+ and CD8+ populations, and 
whether there was accompanying IL-10 production by these cells. 
 
We then selected M. chelonae as the representative Env species for immunisation and 
performed intranasal BCG challenge to examine: 
a. Cell types and cytokines in the bronchoalveolar lavage fluid (BALF)  
b. Lymphocyte proliferation and cytokine production in spleen  
c. Bacterial load in the lungs  
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6.2 CD45RBlow T cells induced in response to Env  
We first compared the differential abilities of different Env species in inducing cells of 
the CD44+ CD45RBlow phenotype which is characteristic of activated memory cells. We 
also studied the proportion of cells of this phenotype within the CD4+ and CD8+ 
populations.  Mice were i.p. immunised thrice in three successive weeks with 1 x 106 
heat-killed BCG, M. avium, M. smegmatis or M. chelonae, and their splenocytes 
harvested for flow cytometry.  PBS immunised mice were used as the negative control.  
The percentage of CD44+CD45RBlow T cells in both CD4+ T cells and CD8+ T cells was 
generally higher in Env-immunised mice than control mice (p < 0.05), with the exception 
of CD8+ cells in M. avium- and M. smegmatis-immunised mice, which were similar to 
controls (Fig. 16). The percentage of CD44+CD45RBlow T cells was comparable between 
different Env-immunised mice, with the exception that CD8+ CD44+CD45RBlow T cells 
in M. chelonae immunised mice were significantly higher than M. smegmatis-immunised 
mice (p = 0.028). 
M. chelonae-immunised mice induced the highest proportion of CD8+CD44+CD45RBlow 
T cells. Overall, the proportion of CD4+CD44+CD45RBlow T cells in M. chelonae- and 
M. smegmatis-immunised mice was slightly higher than M. avium- and BCG-immunised 
mice, but this was not statistically significant.  
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Figure 16: Env immunisation induced diverse frequencies of CD4+CD44+CD45RBlow T 
cells and CD8+CD44+CD45RBlow T cells. CD4+ and CD8+ T cells were first purified by 
positive-selection using magnetic beads. The selected cells were then subjected to CD44 
and CD45RB phenotyping by flow cytometry. Means of triplicate wells are shown, error 
bars indicate 2 SD from the mean. Significant differences between antigen pairs were 
tested using the Student t test. The symbol § indicates data significantly higher than 
control (PBS-immunised) mice. Data represent one out of two independent experiments 







6.3 CD45RBlow IL-10+ T cells induced by Env 
T cells that express low levels of CD45RB and secrete IL-10 are potential regulatory T 
cells (Tregs). To evaluate which species of Env induced higher numbers of Tregs, 
splenocytes from mice subjected to different Env immunisation for three weeks were 
analysed for the presence of potential Tregs by immunostaining. 
 
All three species of Env induced higher percentage of CD45RBlow IL-10+ cells, compared 
to PBS-immunised mice (Fig. 17). Comparing the CD4+ T cells from differentially 
immunised mice, M. chelonae induced highest percentage of CD4+CD45RBlow IL-10+ 
cells among all the species tested. In contrast, comparing the CD8+ T cells, M. smegmatis 
induced highest percentage of CD45RBlow IL-10+ cells, followed by M. chelonae. 
However, overall, the percentage of IL-10+ cells was very low and not significantly 
different between the different Env, although all were higher than control mice.  
Among all the Env tested, as M. chelonae induced high percentages of CD44+CD45RBlow 
cells in both CD4+ and CD8+ populations. Thus, for subsequent work, M. chelonae-
immunised mice were used to uncover the effects of Env on subsequent BCG infection.  
6.4 BCG load in lungs of mice challenged with or without pre-sensitisation 
Mice sensitised with heat-killed M. chelonae or PBS (control) by i.p immunisation were 
subjected to intranasal live BCG challenge one week after the last immunisation. Three 
weeks after challenge, bacterial load was first assayed in the lungs by measuring colony 
forming units (CFU) (Fig. 18). Mice sensitised with M. chelonae had 10-fold fewer CFU 






































Figure 17: Immunisation with different Env induced diverse frequencies of CD45RBlow 
IL-10+ T cells in the CD4+ and CD8+ populations. Mice were i.p. immunised with 1x106 
heat-killed bacteria or PBS for 3 weeks. CD4+ and CD8+ T cells were first purified by 
positive selection using magnetic beads. The selected cells were subjected to surface 
staining (CD45RB) and intracellular cytokine staining (IL-10) before flow cytometry on 
the freshly harvested organs. Figures indicate percentages of CD4+ or CD8+ cells in each 
quadrant, the lower quadrants represent the CD45RBlow population. Data represent one 


























Figure 18: Mice sensitised with M. chelonae had reduced lung CFUs after BCG 
challenge.  Mice were immunised with 1x 106 heat-killed M. chelonae or PBS for 3 
weeks. One week after the last immunisation, mice were infected with 1.25 x 105 BCG by 
the intranasal route (dose given was confirmed by CFU counting). Three weeks after 
challenge, lung tissue was homogenised in ten-fold serial dilutions and CFUs were 
determined. Means of data from three mice are shown, error bars indicate 2 SD from the 
mean. Differences between the two types of mice were tested using the Student t test. 







6.5 Inflammatory responses induced in BALF from BCG-challenged mice with 
or without pre-sensitisation 
Differences in inflammatory responses in the lungs of Env-sensitised and control mice 
were examined following BCG challenge. Cells in the bronchoalveolar lavage fluid 
(BALF) were concentrated on slides and numbers of macrophages, neutrophils, 
lymphocytes and eosinophils were counted after Geimsa-staining (Fig.19A). The 
concentration of cytokines IL-2, IL12p70, IFN-γ, IL-10 and IL-4 in BALF was assayed 
by ELISA (Fig.19B).           
 
Figure 19A showed that there were 10-fold fewer inflammatory cells induced by BCG 
infection in M. chelonae-immunised mice compared to control mice. Levels of cytokines 
in BALF were very low (Fig. 19B). IL12p70 and IL-10 were undetectable in M. 
chelonae-immunised mice. However, IL-2 and IFN-γ levels in BALF of M. chelonae- 
immunised mice were higher than control mice (p<0.05). IL-4 levels were slightly higher 
in M. chelonae-immunised mice, but as there was significant variance within the group, 
this result was not statistically significant. Overall, however, all the cytokine 
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Figure 19: Mice sensitised with M. chelonae had reduced inflammatory responses and 
increased cytokines production in lung after BCG challenge. BALF was obtained three 
weeks after challenge by flushing the lungs with ice-cold PBS. A: Numbers of 
macrophages, neutrophils, lymphocytes, eosinophils were counted, cell numbers per ml 
BALF are presented. B: Concentrations of IL-2, IL12p70, IFN-γ, IL-10 and IL-4 from 
supernatant of BALF were assayed using the Bioplex system. Means of assays from three 
mice per group are shown, error bars indicate 2 SD from the mean. Based on the Student 
t test, *, p < 0.05 comparing between PBS- and M. chelonae- immunised mice. Data 












6.6 Immune response in splenocytes of BCG-challenged mice with or without 
pre-sensitisation 
Splenocytes from mice sensitised with M. chelonae or PBS, followed by i.n. BCG 
challenge, were harvested to test in vitro proliferative responses against heat-killed BCG 
and cytokine production. As shown in figure 20A, splenocytes from mice sensitised with 
M. chelonae showed a significantly higher proliferative response compared with control 
mice (p=0.0037). However, the levels of IL-2, IL12p70 and IL-10 were undetectable in 
the splenocytes. Levels of IFN-γ and IL-4 were similar in M. chelonae-immunised mice 
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Figure 20: Immune responses in splenocytes of sensitised and control mice after BCG 
challenge.  A: Splenocytes were stimulated with heat-killed BCG (bacteria: splenocyte 
ratio 10:1) for 4 days. Proliferative responses were expressed as stimulation index (SI) 
calculated as the mean absorbance reading of triplicates from stimulated wells divided by 
the mean absorbance reading of triplicates from non-stimulated wells. B: Concentrations 
of IFN-γ and IL-4 from supernatants of splenocytes after 48-hour stimulation were 
assayed. Means of three mice per group are shown, error bars indicate 2 SD from the 
mean. Significant differences between the two types of mice were tested using the 
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6.7 Discussion 
6.7.1 Potential ability of inducing memory T cells by Env 
CD44+ is highly expressed on murine memory T cells (Budd et al. 1987; Kaech et al. 
2002). Additionally, accumulating data from genetic and biochemical studies have 
elucidated the role of high and low molecular weight isoforms of CD45 in the function of 
naive and memory T lymphocytes (Tchilian et al., 2002). The present study found that 
there was a significantly higher proportion of CD44+ CD45RBlow in both CD4+ and CD8+ 
T populations following either BCG or M. chelonae immunisation. In contrast, M. avium- 
and M. smegmatis-immunised mice only showed a significantly increased proportion of 
CD4+ cells of the CD44+ CD45RBlow phenotype (Fig. 16). The induction of memory T 
cells by Env forms the basis of the influence of Env on immunity following subsequent 
pathogenic mycobacteria exposure.  
6.7.2 Effect of Env on BCG challenge 
M. chelonae-immunised mice had 10-fold lower BCG counts in the lungs three weeks 
after challenge compared with control mice (Fig. 18). These results are in agreement with 
the classical observation that priming with environmental mycobacteria provides a certain 
level of protective immunity to other mycobacteria (Brown et al., 1985). Studies by 
Brandt et al (Brandt et al., 2002) show that the rapid replication of the pre-sensitised 
mycobacteria managed to block BCG replication and hence reduce its protective efficacy 
against Mtb. They find this effect more pronounced with M. avium than M. chelonae and 
suggest that in contrast to M. avium, which can stably replicate in mice, perhaps M. 
chelonae fails to replicate rapidly and may thus be unable to block the replication of 
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BCG. However, the current work (Fig. 18) showed that M. chelonae-immunised mice did 
have the ability to reduce BCG counts significantly (over non-immunised mice), perhaps 
this discrepancy relates to the difference in the method of sensitization – in their study, 
mice were sensitised with 2 x106 CFU live bacteria subcutaneously three times at two-
week intervals, whereas in the present study, 1 x 106 CFU heat-killed bacteria were 
delivered i.p. three times at one-week interval. Others have previously shown partial 
protection against Mtb conferred by M. avium delivered by aerosol but not 
subcutaneously, so the route of sensitisation clearly plays a role (Orme et al., 1984; Orme 
et al., 1986). How M. chelonae memory responses in this model result in functional 
limitation of BCG growth could been explained, at least in part, by the data in the 
previous chapter showing strong cytotoxicity responses against BCG-infected target cells 
following M. chelonae sensitisation.  
 
In contrast to the observations of Brandt, Demangel et al show that sensitisation with 
certain Env species reduces BCG counts, but without resulting in diminished protective 
efficacy against Mtb challenge (Demangel et al., 2005). They explained the discrepancy 
by suggesting that this may relate to the extent to which BCG growth is blocked by each 
Env species and the natural resistance of the mouse strain employed.  Demangel et al also 
show that M. avium sensitisation results in more effective clearance of BCG than M. 
vaccae and M. scrofulaceum, thus they propose that the inhibitory effect could be related 
to the extent of cross-recognition of environmental mycobacterial antigens and BCG 
antigens. Likewise, the present study showed that sensitisation with M. chelonae, also 
phylogenetically distant from BCG, was able to reduce BCG counts 10-fold but not 
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completely. The reason for the lower extent of BCG inhibition in our study could also be 
because we immunised the mice with heat-killed M. chelonae, whereas the model used 
by Brandt and Demangel involved live Env infection followed by antibiotic treatment to 
kill the Env, prior to BCG challenge. Nonetheless, the heat-killed model was chosen for 
this work because we wished to exclude the possibility that the effects seen by Brandt 
and Demangel were related to Env colonisation of the mice and/or latent Env infection.  
 
6.7.3 Immunomodulatory effects of M. chelonae 
 The inflammatory responses in M. chelonae-immunised mice were lower than naïve 
mice (Fig. 19A) as shown by reduced inflammatory cells in the BALF. Previous studies 
on M. vaccae also show that treatment with this non-pathogenic Mycobacterium species 
prevents ligature-induced periodontal disease which is an inflammatory condition in 
Wistar rats (Breivik et al., 2003). Another study using an allergy model shows that M. 
vaccae–induced allergen-specific CD4+ CD45RBlow regulatory T cells, which produce 
IL-10 and TGF-β , reduce inflammatory responses in mice (Zuany-Amorim et al., 2002). 
Higher proportions of IL-10+CD45RBlow cells, especially in the CD4+ T cells from the M. 
chelonae-immunised mice (Fig. 17), were initially anticipated in view of the latter 
observations. Given that IL-10+ cells were highest in M. chelonae-immunised mice but 
not significantly so, it would be relevant to investigate the role of TGF-β in the 
immunoregulatory response induced by Env, in future work. Thus, there is likely to be a 
potential immunomodulatory role of M. chelonae but the mechanisms involved may not 
be identical to those induced by M. vaccae.  
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In addition, it was found that in murine Mtb infection, heat-killed M. vaccae causes a 
switch from Th2 to Th1 responses, which restores the expression of IL-1α and TNF-α 
associated with a switch from pneumonic response to granuloma formation (Hernandez-
Pando et al., 2000). From our study, IFN-γ in BALF of M. chelonae-sensitised mice were 
significant higher than in naïve mice (Fig. 19) after BCG challenge, even though the 
overall inflammatory cell count was low. IL-4 levels were comparable in the immunised 
and control mice. Thus, the higher levels of Th1 responses in pre-sensitised mice could 
antagonise Th2 responses and contribute to protection against BCG infection. It is 
possible that there is a good balance of regulatory and activated pathogen-specific cells in 
the Env-immunised mice, such that the inflammatory response is not excessive but an 
appropriate T cell response to the pathogen is maintained. Such a response would be 
optimal in a vaccine against TB. 
             
6.7.4 Responses in different organs 
Given that BCG challenge was conducted via the intranasal route in the present study, it 
is not surprising that there was not a significant inflammatory response in the spleen, 
other than an increased proliferation against BCG antigens in M. chelonae-immunised 
mice. The levels of cytokines expressed by splenocytes stimulated with BCG antigens 
were extremely low in both M. chelonae-immunised mice and naïve mice (Fig. 18B). 
BCG, as the attenuated vaccine strain, is not highly virulent and even in Balb/c mice 
(which are susceptible to Mtb), clearance of the pathogen occurs fairly rapidly. From the 
initial challenge with 1.25 x 105 CFU, only about 4 x 103 CFU were recovered three 
weeks after infection (Fig. 18). In further work, earlier time-points for harvesting the 
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organs could be tested, to determine whether the response could have peaked earlier. 
However, Demangel et al note that there is a difference between the extent to which M. 
vaccae and M. scrofulaceum sensitisation affects BCG infection of the lungs and spleen 
in an intravenous infection model (Demangel et al., 2005). In that study, BCG was 
eliminated from the lungs at 3 weeks but the spleen counts were unmodified. This 




M. chelonae-immunised mice had a higher proportion of CD44+ CD45RBlow cells in both 
CD4+ and CD8+ T cell subsets, even though the proportion of CD4+ T cells and CD8+ T 
cells induced by M. chelonae was the lowest among all different Env-immunised mice 
(Fig. 14 and 13). In addition, mice immunised with M. chelonae had reduced bacterial 
loads after BCG challenge, with lower levels of inflammatory cells in the lungs relative 
to naïve mice, but higher Th1 cytokine levels and better splenocyte immune recognition 
of BCG. Taken together, these results suggest that M. chelonae has immunomodulatory 
effects on the host responses to the pathogen, such that protection is increased without 
induction of high levels of inflammation. In connection with the data from the previous 
chapter, it could be suggested that cytotoxic responses against BCG-infected 
macrophages contributed to the limitation of the BCG load. Given the high level of 
homology between BCG and Mtb, M. chelonae may potentially also confer some 
protection against Mtb challenge.  
 
 111
CHAPTER 7    CONCLUSION AND FUTURE WORK 
7.1 Summary of findings 
The present study demonstrated that human Env-induced CD4+ T cells can lyse BCG-
infected autologous macrophages in an IFN-γ independent manner, to a greater extent 
that BCG-responding T cells. Murine Env immunisation signficantly reduced BCG 
multiplication in vivo, with accompanying reduction in lung inflammatory responses but 
increased pathogen-specific T cell responsiveness and Th1 responses. Such Env 
sensitisation conferred a significant increase in CD4+ T cell-mediated cytotoxicity which 
can be restimulated with other Env antigens through cross-reactivity, unlike BCG 
immunisation.  Overall, these results suggest two reasons for the failure of BCG 
vaccination in human populations heavily exposed to Env, and also indicate that certain 
Env species have immunomodulatory properties which may be beneficial in immunity 
against TB. 
 
7.2 Future work 
7.2.1 Roles played by CD8+ T cells in response to Env 
In certain human donors, there was expansion of Env-reactive CD8+ T cells following 
stimulation (Fig. 9). Likewise, this Env-induced CD8+ T cell expansion also occurred in 
mice immunised with selected Env species (Fig. 13). However, cytotoxic activity of Env-
responding cells was found to be independent of CD8+ T cells in both humans (Fig. 8) 
and mice (Fig. 15). It is then desirable to determine other roles played by Env-responding 
CD8+ T cells, such as whether Env-responding CD8+ T cells play a role in protecting the 
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host by clearance of Mtb directly, because it was found that human CD8+ T cells were 
able to kill the intracellular bacteria directly by the release of granulysin via the perforin 
pore (Cho et al., 2000 ).   
 
7.2.2 IL-4 induced by M. chelonae and its implication on vaccine 
Although repeated human immunisation with BCG promotes Th1 responses, it has been 
found to confer no additional protection against Mtb infection (Leal et al., 2001). One 
explanation is that BCG fails to down-regulate IL-4 responses in response to Mtb, when 
compared with another vaccine candidate, heat killed M. vaccae which is successful in 
inducing a switch from type 2 cytokine profile back to a type 1 cytokine profile in a 
murine TB model (Hernandez-Pando et al., 2000). In the human subjects studied here, M. 
chelonae in vitro stimulation induced significantly higher levels of IL-4 and TNF-α 
production and lower IFN-γ in comparison with other Env (Fig. 11 and 2). This is in 
contrast with the murine study suggesting that post-BCG challenge, the M. chelonae-
immunised mice made more IFN-γ in the lungs. It is not clear if this is a difference 
between humans and mice or whether it relates to the presence of the infectious 
challenge. Thus, it would be useful to examine responses to M. chelonae in human TB 
patients.  
 
7.2.3 Mechanism of regulatory property of M. chelonae 
Reduced BCG counts and inflammatory responses in the lungs of M. chelonae-
immunised mice relative to naïve mice were observed in this study (Fig. 18 and 19A), 
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suggesting an immunomodulatory effect induced by M. chelonae.  IL-10 producing cells 
were detected in both CD4+ T cells and CD8+ T cells of M. chelonae-immunised mice, 
but the levels were not appreciable. Thus the detailed phenotypic properties of M. 
chelonae-responsive cells and the pathway of regulation responsible for this 
immunomodulation need to be investigated. Adoptive transfer of CD45RBhigh and 
CD45RBlow CD4+ T cells of Env-immunised mice to naïve mice, with BCG challenge, 
may help to determine the functional cell types involved. Additionally, monoclonal 
antibodies against IL-10 and TGF-β used to block these cytokines in the Env-immunised 
mice may further clarify whether these cytokines are critical in this regulatory function. 
Such findings may help us to identify the desirable components of the M. chelonae 
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Middlebrook 7H9 broth 
 
Volume Distilled  7H9 broth 50% 20% OADC 
     water   powder 
 
Glycerol Tween 20   
400 ml 356.4 ml 1.88 g 1.6 ml 2 ml 40 ml 
All ingredients were added and autoclaved at 121 °C for 15 min. OADC was added  
before use. 
 
Middlebrook 7H10 broth 
 
Volume Distilled  
7H10 
broth 50% 20% OADC 
     water   powder 
 
Glycerol Tween 20   
400 ml 353.6 ml 7.6 g 4 ml 2 ml 40 ml 
All ingredients were added and autoclaved at 121 °C for 15 min. The agar was left to  
cool to 55 °C before OADC was added. The liquefied  agar was aliquoted into 60 mm  
Petri dishes and allowed to set. 
 
Complete supplement for BCG infection (10X FAC) 
 





     water citrate (FAC) glutamin   
50 ml 50 ml 25 mg 1 g 1 g 
All ingredients were added at room temperature and mixed by stirring.  Medium was  
sterilised by filter through a 0.22 μm filter.  
 





     water       (NH4cl) 
10 ml 10 ml 90 mg 
All ingredients were added at room temperature and mixed by stirring.  Adjust pH to  





Asparagine KH2PO4 MgSO4· 7H2O
Citric 
acid 100%glycerol
1 L 4 g 0.5 g 0.5 g 2 g 60 ml 
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All ingredients were added at room temperature and mixed by stirring.  Adjust pH to  
7.3 and top up with distilled water to 1 L. Autoclave at 121 °C for 15 min. Store at 4 °C 
before use. 
 
 
